https://www.med-life.it/number_articles/ad-n-2672021-neuropatia-ottica-indotta-farmaci/__pag_1093_tab_2/ 2022-07-29T08:42:39+00:00 https://www.med-life.it/number_articles/ad-n-2672021-neuropatia-ottica-indotta-farmaci/__pag_1094_biblio/ 2022-07-29T08:46:06+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_114_raccomandazioni/ 2022-07-29T09:33:00+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_115_tab_1/ 2022-07-29T09:37:39+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_116_tab_2/ 2022-07-29T09:42:44+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_117_tab_3/ 2022-07-29T12:48:12+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_118_tab_4/ 2022-07-29T12:49:58+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_119_tab_5/ 2022-07-29T12:50:46+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_119_biblio_1/ 2022-07-29T12:51:32+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_119_biblio_2/ 2022-07-29T12:52:04+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_120_biblio_3/ 2022-07-29T12:52:35+00:00 https://www.med-life.it/number_articles/tml-n-15-2022-farmaci-trattamento-la-prevenzione-del-tromboembolismo-venoso/__pag_120_biblio_4/ 2022-07-29T12:53:04+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-la-fda-autorizza-vaccino-novavax-la-covid-19/__pag_122_art_1_tab_1/ 2022-08-10T11:15:57+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-la-fda-autorizza-vaccino-novavax-la-covid-19/__pag_122_art_1_biblio/ 2022-08-10T11:18:21+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-la-fda-autorizza-vaccino-novavax-la-covid-19/__pag_122_art_1_biblio-2/ 2022-08-10T11:18:47+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-tapinarof-crema-la-psoriasi/__pag_122_art_2_tab_1/ 2022-08-10T11:32:31+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-tapinarof-crema-la-psoriasi/__pag_123_art_2_tab_2/ 2022-08-10T11:33:56+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-tapinarof-crema-la-psoriasi/__pag_123_art_2_punti_chiave/ 2022-08-10T11:34:56+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-tapinarof-crema-la-psoriasi/__pag_122_art_2_tab_1-2/ 2022-08-10T11:35:24+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-tapinarof-crema-la-psoriasi/__pag_124_art_2_biblio/ 2022-08-10T11:36:59+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-oteseconazolo-la-candidosi-vulvovaginale-ricorrente/__pag_124_art_3_punti_chiave/ 2022-08-10T11:42:16+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-oteseconazolo-la-candidosi-vulvovaginale-ricorrente/__pag_125_art_4_tab_1/ 2022-08-10T11:45:19+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-oteseconazolo-la-candidosi-vulvovaginale-ricorrente/__pag_126_art_4_biblio/ 2022-08-10T11:46:51+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-lumateperone-la-depressione-bipolare/__pag_127_art_5_punti_chiave/ 2022-08-10T11:54:53+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-lumateperone-la-depressione-bipolare/__pag_127_art_5_tab_1/ 2022-08-10T11:55:51+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-lumateperone-la-depressione-bipolare/__pag_128_art_5_tab_2/ 2022-08-10T11:57:18+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-lumateperone-la-depressione-bipolare/__pag_128_art_5_biblio/ 2022-08-10T11:57:42+00:00 https://www.med-life.it/number_articles/tml-n-16-2022-lumateperone-la-depressione-bipolare/__pag_128_art_5_biblio-2/ 2022-08-10T11:58:19+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_129_punti_chiave/ 2022-08-22T08:55:53+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_131_tab_1/ 2022-08-22T09:05:28+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_132_tab_1_segue/ 2022-08-22T09:06:07+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_135_biblio_1/ 2022-08-22T09:06:38+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_135_biblio_2/ 2022-08-22T09:07:10+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_135_biblio_3/ 2022-08-22T09:07:35+00:00 https://www.med-life.it/number_articles/tml-n-17-2022-farmaci-declino-cognitivo-la-demenza/__pag_135_biblio_4/ 2022-08-22T09:08:12+00:00 https://www.med-life.it/number_articles/ad-n-2682022-le-nuove-raccomandazioni-terapeutiche-lasma-aumenteranno-gli-eventi-avversi/__pag_1096_tab_1/ 2022-09-06T09:26:06+00:00 https://www.med-life.it/number_articles/ad-n-2682022-le-nuove-raccomandazioni-terapeutiche-lasma-aumenteranno-gli-eventi-avversi/__pag_1097_tab_1_segue/ 2022-09-06T09:26:30+00:00 https://www.med-life.it/number_articles/ad-n-2682022-le-nuove-raccomandazioni-terapeutiche-lasma-aumenteranno-gli-eventi-avversi/__pag_1098_tab_2/ 2022-09-06T09:26:59+00:00 https://www.med-life.it/number_articles/ad-n-2682022-le-nuove-raccomandazioni-terapeutiche-lasma-aumenteranno-gli-eventi-avversi/__pag_1098_biblio_1/ 2022-09-06T09:27:54+00:00 https://www.med-life.it/number_articles/ad-n-2682022-le-nuove-raccomandazioni-terapeutiche-lasma-aumenteranno-gli-eventi-avversi/__pag_1098_biblio_2/ 2022-09-06T09:28:19+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-prevenzione-trattamento-del-vaiolo-delle-scimmie/__pag_137_art_1_tab_1/ 2022-09-06T09:53:45+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-prevenzione-trattamento-del-vaiolo-delle-scimmie/__pag_138_art_1_tab_2/ 2022-09-06T09:56:39+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-prevenzione-trattamento-del-vaiolo-delle-scimmie/__pag_139_art_1_tab_3/ 2022-09-06T10:01:15+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-prevenzione-trattamento-del-vaiolo-delle-scimmie/__pag_139_art_1_biblio/ 2022-09-06T10:01:59+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-baricitinib-lalopecia-areata-grave/__pag_140_art_2_farmacologia/ 2022-09-06T10:11:06+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-baricitinib-lalopecia-areata-grave/__pag_140_art_2_tab_1/ 2022-09-06T10:12:46+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-baricitinib-lalopecia-areata-grave/__pag_140_art_2_punti_chiave/ 2022-09-06T10:13:19+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-baricitinib-lalopecia-areata-grave/__pag_140_art_2_biblio_1/ 2022-09-06T10:15:12+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-baricitinib-lalopecia-areata-grave/__pag_141_art_2_biblio_2/ 2022-09-06T10:15:38+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-nalmefene-trattamento-del-sovradosaggio-oppioidi/__pag_141_art_3_farmacologia/ 2022-09-06T12:12:50+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-nalmefene-trattamento-del-sovradosaggio-oppioidi/__pag_141_art_3_tab_1/ 2022-09-06T12:14:05+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-nalmefene-trattamento-del-sovradosaggio-oppioidi/__pag_142_art_3_punti_chiave/ 2022-09-06T12:14:54+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-nalmefene-trattamento-del-sovradosaggio-oppioidi/__pag_142_art_3_biblio_1/ 2022-09-06T12:15:35+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-upadacitinib-un-secondo-inibitore-delle-jak-la-colite-ulcerosa/__pag_142_art_4_punti_chiave/ 2022-09-06T12:20:59+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-upadacitinib-un-secondo-inibitore-delle-jak-la-colite-ulcerosa/__pag_142_art_4_farmacologia/ 2022-09-06T12:22:21+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-upadacitinib-un-secondo-inibitore-delle-jak-la-colite-ulcerosa/__pag_143_art_4_tab_1/ 2022-09-06T12:22:59+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-upadacitinib-un-secondo-inibitore-delle-jak-la-colite-ulcerosa/__pag_143_art_4_tab_2/ 2022-09-06T12:23:30+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-upadacitinib-un-secondo-inibitore-delle-jak-la-colite-ulcerosa/__pag_144_art_4_tab_3/ 2022-09-06T12:25:08+00:00 https://www.med-life.it/number_articles/tml-n-18-2022-upadacitinib-un-secondo-inibitore-delle-jak-la-colite-ulcerosa/__pag_144_art_4_biblio_1/ 2022-09-06T12:26:22+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_145_punti_chiave/ 2022-09-20T07:41:01+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_148_tab_1/ 2022-09-20T08:29:29+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_149_tab_1_segue/ 2022-09-20T08:30:38+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_151_biblio_1/ 2022-09-20T10:22:38+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_151_biblio_2/ 2022-09-20T10:22:46+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_152_biblio_3/ 2022-09-20T10:22:53+00:00 https://www.med-life.it/number_articles/tml-n-19-2022-farmaci-ipolipemizzanti/__pag_152_biblio_4/ 2022-09-20T10:22:59+00:00 https://www.med-life.it/privacy-e-cookie-policy/attachment/111996491/ 2022-09-27T21:52:03+00:00 https://www.med-life.it/privacy-e-cookie-policy/iubenda1-js/ 2022-09-27T21:52:04+00:00 https://www.med-life.it/fakeshare/www-fakeshare-eu/ 2022-09-27T21:52:13+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccino-antinfluenzale-la-stagione-2022-2023/__pag_153_art_1_tab_1/ 2022-09-28T18:54:12+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccino-antinfluenzale-la-stagione-2022-2023/__pag_154_art_1_punti_chiave/ 2022-09-28T18:55:00+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccino-antinfluenzale-la-stagione-2022-2023/__pag_155_art_1_tab_2/ 2022-09-28T18:57:23+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccino-antinfluenzale-la-stagione-2022-2023/__pag_156_art_1_biblio_1/ 2022-09-28T19:00:19+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccino-antinfluenzale-la-stagione-2022-2023/__pag_157_art_1_biblio_2/ 2022-09-28T19:00:33+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccino-antinfluenzale-la-stagione-2022-2023/__pag_157_art_1_biblio_3/ 2022-09-28T19:00:52+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-ruxolitinib-crema-la-vitiligine-non-segmentale/__pag_158_art_2_farmacologia/ 2022-09-28T19:07:57+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-ruxolitinib-crema-la-vitiligine-non-segmentale/__pag_158_art_2_punti_chiave/ 2022-09-28T19:08:13+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-ruxolitinib-crema-la-vitiligine-non-segmentale/__pag_158_art_2_tab_1/ 2022-09-28T19:10:13+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-ruxolitinib-crema-la-vitiligine-non-segmentale/__pag_159_art_2_biblio/ 2022-09-28T19:12:03+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccini-richiamo-bivalenti-pfizer-moderna-la-covid-19/__pag_159_agg_covid_tab_1/ 2022-09-28T19:25:18+00:00 https://www.med-life.it/number_articles/tml-n-20-2022-vaccini-richiamo-bivalenti-pfizer-moderna-la-covid-19/__pag_160_agg_covid_biblio_1/ 2022-09-28T19:26:35+00:00 https://www.med-life.it/?attachment_id=26603 2022-10-01T13:19:15+00:00 https://www.med-life.it/?attachment_id=26604 2022-10-03T09:43:09+00:00 https://www.med-life.it/?attachment_id=26622 2022-10-06T21:04:54+00:00 https://www.med-life.it/?attachment_id=26623 2022-10-06T21:05:49+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_162_tab_1/ 2022-10-15T12:51:58+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_163_tab_1_segue/ 2022-10-15T12:52:47+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_164_tab_2/ 2022-10-15T13:41:08+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_165_tab_3/ 2022-10-15T13:42:05+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_166_tab_4/ 2022-10-15T13:43:04+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_166_tab_5/ 2022-10-15T13:43:52+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_167_biblio_1/ 2022-10-15T13:44:25+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_167_biblio_2/ 2022-10-15T13:44:36+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_168_biblio_3/ 2022-10-15T13:44:50+00:00 https://www.med-life.it/number_articles/tml-n-21-2022-immunizzazione-degli-adulti/_pag_168_biblio_4/ 2022-10-15T13:45:05+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1102_tab_1/ 2022-10-18T21:17:38+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1102_tab_2/ 2022-10-18T21:17:53+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1103_tab_3/ 2022-10-18T21:21:11+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1103_tab_4/ 2022-10-18T21:21:27+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1103_biblio_1/ 2022-10-18T21:24:52+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1104_biblio_2/ 2022-10-18T21:25:03+00:00 https://www.med-life.it/number_articles/ad-n-2692022-esperienze-delladverse-drug-event-manager/__pag_1104_biblio_3/ 2022-10-18T21:25:20+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-associazioni-vonoprazan-h-pylori/__pag_169_art_1_punti_chiave/ 2022-11-08T20:10:39+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-associazioni-vonoprazan-h-pylori/__pag_170_art_1_farmacologia/ 2022-11-08T20:11:35+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-associazioni-vonoprazan-h-pylori/__pag_170_art_1_tab_1/ 2022-11-08T20:13:07+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-associazioni-vonoprazan-h-pylori/__pag_171_art_1_tab_2/ 2022-11-08T20:15:34+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-associazioni-vonoprazan-h-pylori/__pag_172_art_1_biblio/ 2022-11-08T20:18:08+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-nuovi-prodotti-base-testosterone-orale-lipogonadismo/__pag_173_art_2_punti_chiave/ 2022-11-08T20:24:27+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-nuovi-prodotti-base-testosterone-orale-lipogonadismo/__pag_173_art_2_tab_1/ 2022-11-08T20:26:17+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-due-nuovi-prodotti-base-testosterone-orale-lipogonadismo/__pag_174_art_2_biblio/ 2022-11-08T20:27:47+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-inibitori-della-fosfodiesterasi-5-la-malattia-alzheimer/__pag_175_art_3_biblio_1/ 2022-11-08T20:33:25+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-inibitori-della-fosfodiesterasi-5-la-malattia-alzheimer/__pag_175_art_3_biblio_2/ 2022-11-08T20:34:00+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-azelastina-spray-nasale-allo-015-la-rinite-allergica/__pag_176_art_4_tab_1/ 2022-11-08T20:38:51+00:00 https://www.med-life.it/number_articles/tml-n-22-2022-azelastina-spray-nasale-allo-015-la-rinite-allergica/__pag_176_art_4_biblio/ 2022-11-08T20:39:36+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_177_abbreviazioni/ 2022-11-22T20:33:41+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_177_punti_chiave/ 2022-11-22T20:34:23+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_178_tab_1/ 2022-11-22T20:35:53+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_178_tab_2/ 2022-11-22T20:37:05+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_179_tab_3/ 2022-11-22T20:37:58+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_180_tab_4/ 2022-11-22T20:42:10+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_181_tab_4_segue/ 2022-11-22T20:43:06+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_182_tab_4_segue/ 2022-11-22T20:44:02+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_183_tab_5/ 2022-11-22T20:45:39+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_184_bibliografia_1/ 2022-11-22T20:47:55+00:00 https://www.med-life.it/number_articles/tml-n-23-2022-farmaci-diabete-tipo-2/__pag_184_bibliografia_2/ 2022-11-22T20:48:43+00:00 https://www.med-life.it/?attachment_id=27170 2022-11-29T21:26:52+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-antivirali-la-stagione-influenzale-2022-2023/__pag_185_art_1_tab_1/ 2022-12-06T17:31:08+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-antivirali-la-stagione-influenzale-2022-2023/__pag_186_art_1_tab_2/ 2022-12-06T17:32:22+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-antivirali-la-stagione-influenzale-2022-2023/__pag_187_art_1_tab_2_segue/ 2022-12-06T17:33:14+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-antivirali-la-stagione-influenzale-2022-2023/__pag_189_art_1_bilio_1/ 2022-12-06T17:34:47+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-antivirali-la-stagione-influenzale-2022-2023/__pag_189_art_1_bilio_2/ 2022-12-06T17:35:02+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-unassociazione-dose-fissa-fenilbutirrato-sodio-taurursodiolo-la-sla/__pag_191_art_2_punti_chiave/ 2022-12-06T17:43:16+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-unassociazione-dose-fissa-fenilbutirrato-sodio-taurursodiolo-la-sla/__pag_191_art_2_biblio_1/ 2022-12-06T17:44:25+00:00 https://www.med-life.it/number_articles/tml-n-24-2022-unassociazione-dose-fissa-fenilbutirrato-sodio-taurursodiolo-la-sla/__pag_192/ 2022-12-06T17:47:08+00:00 https://www.med-life.it/?attachment_id=26618 2022-12-09T09:39:25+00:00 https://www.med-life.it/number_articles/tml-n-25-2022-oppioidi-dolore/__pag_194_tab_1/ 2022-12-15T16:22:03+00:00 https://www.med-life.it/number_articles/tml-n-25-2022-oppioidi-dolore/__pag_196_tab_2/ 2022-12-16T00:33:53+00:00 https://www.med-life.it/number_articles/tml-n-25-2022-oppioidi-dolore/__pag_197_tab_2_segue/ 2022-12-16T00:34:40+00:00 https://www.med-life.it/number_articles/tml-n-25-2022-oppioidi-dolore/__pag_199_biblio_1/ 2022-12-16T00:35:29+00:00 https://www.med-life.it/number_articles/tml-n-25-2022-oppioidi-dolore/__pag_199_biblio_2/ 2022-12-16T00:35:48+00:00 https://www.med-life.it/number_articles/tml-n-25-2022-oppioidi-dolore/__pag_200/ 2022-12-16T00:50:10+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-associazione-destrometorfano-bupropione-la-depressione/__pag_202_art_1_farmacologia/ 2022-12-20T20:51:41+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-associazione-destrometorfano-bupropione-la-depressione/__pag_203_art_1_biblio/ 2022-12-20T20:54:28+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-dexmedetomidina-film-sublinguale-lagitazione-acuta/__pag_204_art_2_farmacologia/ 2022-12-20T21:00:41+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-dexmedetomidina-film-sublinguale-lagitazione-acuta/__pag_204_art_2_tab_1/ 2022-12-20T21:02:16+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-dexmedetomidina-film-sublinguale-lagitazione-acuta/__pag_205_art_2_tab_2/ 2022-12-20T21:03:48+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-dexmedetomidina-film-sublinguale-lagitazione-acuta/__pag_205_art_2_biblio/ 2022-12-20T21:05:06+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-risankizumab-un-antagonista-23-la-malattia-crohn/__pag_206_art_3_farmacologia/ 2022-12-20T21:10:16+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-risankizumab-un-antagonista-23-la-malattia-crohn/__pag_206_art_3_tab_1/ 2022-12-20T21:12:24+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-risankizumab-un-antagonista-23-la-malattia-crohn/__pag_207_art_3_tab_2/ 2022-12-20T21:13:06+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-risankizumab-un-antagonista-23-la-malattia-crohn/__pag_207_art_3_biblio/ 2022-12-20T21:14:24+00:00 https://www.med-life.it/number_articles/tml-n-26-2022-minoxidil-orale-la-perdita-dei-capelli/__pag_208_in_breve_biblio/ 2022-12-20T21:19:41+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-farmaci-linsonnia-cronica/__pag_1_art_1_punti_chiave/ 2023-01-18T22:42:03+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-farmaci-linsonnia-cronica/__pag_2_art_1_tab_1-2/ 2023-01-18T22:42:47+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-farmaci-linsonnia-cronica/__pag_5_art_1_biblio_1/ 2023-01-18T22:56:44+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-farmaci-linsonnia-cronica/__pag_6_art_1_biblio_2/ 2023-01-18T22:57:23+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-farmaci-linsonnia-cronica/__pag_6_art_1_biblio_3/ 2023-01-18T22:57:39+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-teplizumab-ritardare-linsorgenza-del-diabete-tipo-1/__pag_7_art_2_tab_1/ 2023-01-18T23:11:41+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-teplizumab-ritardare-linsorgenza-del-diabete-tipo-1/__pag_8_art_2_biblio/ 2023-01-18T23:12:16+00:00 https://www.med-life.it/number_articles/tml-n-1-2023-teplizumab-ritardare-linsorgenza-del-diabete-tipo-1/__pag_8_pubblicita-2/ 2023-01-18T23:12:29+00:00 https://www.med-life.it/number_articles/ad-n-2702022-sicurezza-ed-efficacia-del-naprossene-la-febbre-dolore-acuto-nei-bambini-eta-prescolare-revisione-sistematica/__pag_1106_tab_1/ 2023-01-25T10:25:28+00:00 https://www.med-life.it/number_articles/ad-n-2702022-sicurezza-ed-efficacia-del-naprossene-la-febbre-dolore-acuto-nei-bambini-eta-prescolare-revisione-sistematica/__pag_1108_biblio/ 2023-01-25T10:26:13+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-terapia-genica-lemofilia-b/__pag_9_art_1_punti_chiave/ 2023-01-25T22:52:02+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-terapia-genica-lemofilia-b/__pag_10_art_1_biblio/ 2023-01-25T22:54:00+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-roflumilast-topico-la-psoriasi-placche/__pag_10_art_2_punti_chiave/ 2023-01-25T22:59:18+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-roflumilast-topico-la-psoriasi-placche/__pag_10_art_2_tab_1/ 2023-01-25T23:00:38+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-roflumilast-topico-la-psoriasi-placche/__pag_11_art_2_tab_2/ 2023-01-25T23:01:43+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-roflumilast-topico-la-psoriasi-placche/__pag_11_art_2_tab_3/ 2023-01-25T23:04:10+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-roflumilast-topico-la-psoriasi-placche/__pag_11_art_2_biblio/ 2023-01-25T23:05:29+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-roflumilast-topico-la-psoriasi-placche/__pag_12_art_2_biblio-2/ 2023-01-25T23:06:06+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-olopatadinamometasone-la-rinite-allergica/__pag_12_art_3_punti_chiave/ 2023-01-25T23:11:28+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-olopatadinamometasone-la-rinite-allergica/__pag_12_art_3_tab_1/ 2023-01-25T23:12:10+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-olopatadinamometasone-la-rinite-allergica/__pag_13_art_3_tab_2/ 2023-01-25T23:13:41+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-olopatadinamometasone-la-rinite-allergica/__pag_14_art_3_biblio_1/ 2023-01-25T23:16:54+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-furosemide-sc-linsufficienza-cardiaca/__pag_14_in_breve_biblio_1/ 2023-01-25T23:21:26+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-finerenone-la-malattia-renale-diabetica/__pag_16_in_breve_2_biblio/ 2023-01-25T23:26:46+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-finerenone-la-malattia-renale-diabetica/__pag_15_in_breve_2_tab_1/ 2023-01-25T23:27:39+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-finerenone-la-malattia-renale-diabetica/__pag_15_in_breve_2_tab_2/ 2023-01-25T23:28:37+00:00 https://www.med-life.it/number_articles/tml-n-2-2023-finerenone-la-malattia-renale-diabetica/__pag_16_pubblicita/ 2023-01-25T23:29:14+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-lecanemab-la-malattia-alzheimer/art-1_pag_17/ 2023-02-04T10:23:30+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-lecanemab-la-malattia-alzheimer/art-1_pag_18_tab1/ 2023-02-04T10:25:02+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-lecanemab-la-malattia-alzheimer/art-1_pag_18_desc/ 2023-02-04T10:26:41+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-dupilumab-lesofagite-eosinofila-la-prurigo-nodulare/art-2_pag_19_tab1/ 2023-02-04T10:31:31+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-dupilumab-lesofagite-eosinofila-la-prurigo-nodulare/art-2_pag_19/ 2023-02-04T10:34:28+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-dupilumab-lesofagite-eosinofila-la-prurigo-nodulare/art-2_pag_20_tab2/ 2023-02-04T10:35:15+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-dupilumab-lesofagite-eosinofila-la-prurigo-nodulare/art-2_pag_20_desc/ 2023-02-04T10:37:53+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-dupilumab-lesofagite-eosinofila-la-prurigo-nodulare/art-2_pag_20_desc2/ 2023-02-04T10:38:44+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-crema-base-benzoilperossido-la-rosacea/art-3_pag_21_tab1/ 2023-02-04T10:43:57+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-crema-base-benzoilperossido-la-rosacea/art-3_pag_21/ 2023-02-04T10:44:38+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-crema-base-benzoilperossido-la-rosacea/art-3_pag_21_tab2/ 2023-02-04T10:46:06+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-crema-base-benzoilperossido-la-rosacea/art-3_pag_22_desc1/ 2023-02-04T10:48:02+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-crema-base-benzoilperossido-la-rosacea/art-3_pag_22_desc2/ 2023-02-04T10:48:41+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-destroamfetamina-transdermica-ladhd/art-4_pag_22/ 2023-02-04T10:52:28+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-destroamfetamina-transdermica-ladhd/art-4_pag23_tab1/ 2023-02-04T10:53:46+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-destroamfetamina-transdermica-ladhd/art-4_pag23_desc/ 2023-02-04T10:55:19+00:00 https://www.med-life.it/number_articles/tml-n-3-2023-destroamfetamina-transdermica-ladhd/pubblicita/ 2023-02-04T10:56:44+00:00 https://www.med-life.it/number_articles/ad-n-2712023-uso-controverso-dei-conservanti-nei-colliri-la-tossicita-del-benzalconio-cloruro/bibio_1/ 2023-02-25T17:43:20+00:00 https://www.med-life.it/number_articles/ad-n-2712023-uso-controverso-dei-conservanti-nei-colliri-la-tossicita-del-benzalconio-cloruro/biblio_2-2/ 2023-02-25T17:43:35+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-farmaci-lipotiroidismo/art-1_pag_25_tab1/ 2023-02-25T17:53:05+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-farmaci-lipotiroidismo/art-1_pag_26_tab1/ 2023-02-25T17:54:12+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-farmaci-lipotiroidismo/art-1_pag_27_tab2/ 2023-02-25T17:58:28+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-farmaci-lipotiroidismo/art-3_pag28_desc/ 2023-02-25T18:00:45+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-deucravacitinib-la-psoriasi-placche/art-2_pag29_tab1/ 2023-02-25T18:07:00+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-deucravacitinib-la-psoriasi-placche/art-2_pag29_tab2/ 2023-02-25T18:08:09+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-deucravacitinib-la-psoriasi-placche/art-2_pag29_tab3/ 2023-02-25T18:09:22+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-deucravacitinib-la-psoriasi-placche/art-2_pag30_tab3/ 2023-02-25T18:10:26+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-deucravacitinib-la-psoriasi-placche/art-2_pag30_desc1/ 2023-02-25T18:12:43+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-ampliamento-dellindicazione-del-mifepristone/art-3_pag31_desc1/ 2023-02-25T18:17:49+00:00 https://www.med-life.it/number_articles/tml-n-4-2023-semaglutide-la-perdita-peso-nei-bambini/art-2_pag32_desc1/ 2023-02-25T18:20:50+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-farmaci-antivirali-la-covid-19-nei-pazienti-ambulatoriali-vaccinati/art-1_pag_33_tab1/ 2023-03-04T16:32:48+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-farmaci-antivirali-la-covid-19-nei-pazienti-ambulatoriali-vaccinati/art-1_pag_34_tab2/ 2023-03-04T16:33:32+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-farmaci-antivirali-la-covid-19-nei-pazienti-ambulatoriali-vaccinati/art-1_pag_35_descr/ 2023-03-04T16:35:19+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-farmaci-antivirali-la-covid-19-nei-pazienti-ambulatoriali-vaccinati/art-1_pag_34_descr/ 2023-03-04T16:35:32+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-microbiota-fecale-vivo-la-prevenzione-delle-recidive-cdi/art-2_pag_35/ 2023-03-04T16:41:32+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-microbiota-fecale-vivo-la-prevenzione-delle-recidive-cdi/art-2_pag_36_desc/ 2023-03-04T16:43:53+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-ublituximab-la-sclerosi-multipla-recidivante/art-3_pag_36_tab/ 2023-03-04T16:48:12+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-ublituximab-la-sclerosi-multipla-recidivante/art-3_pag_37_tab1/ 2023-03-04T16:48:53+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-ublituximab-la-sclerosi-multipla-recidivante/art-3_pag_37_tab2/ 2023-03-04T16:50:20+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-ublituximab-la-sclerosi-multipla-recidivante/art-3_pag_37_tab3/ 2023-03-04T16:51:24+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-ublituximab-la-sclerosi-multipla-recidivante/art-3_pag_38_desc/ 2023-03-04T16:53:01+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-elacestrant-carcinoma-mammario-stadio-avanzato-metastatico/art-4_pag_38_tab1/ 2023-03-04T16:57:00+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-elacestrant-carcinoma-mammario-stadio-avanzato-metastatico/art-4_pag_39_tab2/ 2023-03-04T16:57:12+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-elacestrant-carcinoma-mammario-stadio-avanzato-metastatico/art-4_pag_39_tab3/ 2023-03-04T16:57:28+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-elacestrant-carcinoma-mammario-stadio-avanzato-metastatico/art-4_pag_40_desc/ 2023-03-04T17:00:33+00:00 https://www.med-life.it/number_articles/tml-n-5-2023-elacestrant-carcinoma-mammario-stadio-avanzato-metastatico/art-4_pag_40_tab/ 2023-03-04T17:00:49+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-farmaci-la-vescica-iperattiva/art-1_pag_41_tab1/ 2023-03-19T11:28:09+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-farmaci-la-vescica-iperattiva/art-1_pag_42_tab1/ 2023-03-19T11:34:26+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-farmaci-la-vescica-iperattiva/art-1_pag_44_desc/ 2023-03-19T11:35:21+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-farmaci-la-vescica-iperattiva/art-1_pag_45_desc/ 2023-03-19T11:36:10+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-un-inserto-oftalmico-desametasone-la-congiuntivite-allergica/art-2_pag_45_tab1/ 2023-03-19T11:43:50+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-un-inserto-oftalmico-desametasone-la-congiuntivite-allergica/art-2_pag_45_tab2/ 2023-03-19T11:45:52+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-un-inserto-oftalmico-desametasone-la-congiuntivite-allergica/art-2_pag_46_desc/ 2023-03-19T11:47:13+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-terlipressina-la-sindrome-epatorenale/art-3_pag_46_tab1/ 2023-03-19T11:53:09+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-terlipressina-la-sindrome-epatorenale/art-3_pag_47_tab2/ 2023-03-19T11:54:02+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-terlipressina-la-sindrome-epatorenale/art-3_pag_47_desc/ 2023-03-19T11:55:23+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-terlipressina-la-sindrome-epatorenale/art-3_pag_48_desc/ 2023-03-19T11:56:12+00:00 https://www.med-life.it/number_articles/tml-n-6-2023-amitriptilina-off-label-linsonnia/art-4_pag_48_desc2/ 2023-03-19T11:59:51+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-pegcetacoplan-latrofia-geografica-nella-degenerazione-maculare-legata-alleta/art-1_pag_49_tab1/ 2023-03-30T19:43:14+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-pegcetacoplan-latrofia-geografica-nella-degenerazione-maculare-legata-alleta/art-1_pag_49_tab2/ 2023-03-30T19:43:55+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-pegcetacoplan-latrofia-geografica-nella-degenerazione-maculare-legata-alleta/art-1_pag_50_tab1/ 2023-03-30T19:44:55+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-pegcetacoplan-latrofia-geografica-nella-degenerazione-maculare-legata-alleta/art-1_pag_50_desc/ 2023-03-30T19:46:56+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_51_tab1/ 2023-03-30T19:53:42+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_52_tab2/ 2023-03-30T19:54:26+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_53_tab1/ 2023-03-30T19:56:31+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_54_tab1/ 2023-03-30T19:58:59+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_54_tab2/ 2023-03-30T19:59:45+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_55_tab3/ 2023-03-30T20:02:09+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_55_descr1/ 2023-03-30T20:02:55+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-tre-farmaci-la-dermatite-atopica/art-2_pag_55_descr2/ 2023-03-30T20:03:15+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-un-altro-prodotto-base-insulina-glargine-intercambiabile-lantus/art-3_pag_56_tab1/ 2023-03-30T20:10:43+00:00 https://www.med-life.it/number_articles/tml-n-7-2023-un-altro-prodotto-base-insulina-glargine-intercambiabile-lantus/art-3_pag_56_desc/ 2023-03-30T20:11:28+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-trattamento-delle-comuni-infezioni-respiratorie/art-1_pag58_tab1/ 2023-04-15T21:47:40+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-trattamento-delle-comuni-infezioni-respiratorie/art-1_pag58_tab2/ 2023-04-15T21:48:36+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-trattamento-delle-comuni-infezioni-respiratorie/art-1_pag62_desc/ 2023-04-15T21:54:06+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-trattamento-delle-comuni-infezioni-respiratorie/art-1_pag62_desc2/ 2023-04-15T21:54:50+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-esiti-cardiovascolari-lacido-bempedoico/art-2_pag_63_tab1/ 2023-04-15T22:04:13+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-esiti-cardiovascolari-lacido-bempedoico/art-2_pag63_desc/ 2023-04-15T22:05:18+00:00 https://www.med-life.it/number_articles/tml-n-8-2023-dose-richiamo-del-vaccino-bivalente-prodotto-pfizer-bambini-eta-compresa-6-mesi-4-anni/art-2_pag64_desc/ 2023-04-15T22:09:27+00:00 https://www.med-life.it/number_articles/ad-n-2722023-sicurezza-degli-agonisti-del-recettore-del-peptide-1-glucagone-simile-la-gestione-del-peso-adulti-adolescenti-bambini-affetti-obesita-revisione-sistematica/ad_272_apr-2023-tab1/ 2023-04-25T17:58:20+00:00 https://www.med-life.it/number_articles/ad-n-2722023-sicurezza-degli-agonisti-del-recettore-del-peptide-1-glucagone-simile-la-gestione-del-peso-adulti-adolescenti-bambini-affetti-obesita-revisione-sistematica/ad_272_apr-2023-tab2/ 2023-04-25T17:59:57+00:00 https://www.med-life.it/number_articles/ad-n-2722023-sicurezza-degli-agonisti-del-recettore-del-peptide-1-glucagone-simile-la-gestione-del-peso-adulti-adolescenti-bambini-affetti-obesita-revisione-sistematica/ad_272_apr-2023-biblio/ 2023-04-25T18:14:01+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-capsula-orale-produce-vibrazioni-la-stipsi-idiopatica-cronica/art-1_pag65_puntichiave/ 2023-05-02T20:21:58+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-capsula-orale-produce-vibrazioni-la-stipsi-idiopatica-cronica/art-1_pag66_tab1/ 2023-05-02T20:24:57+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-capsula-orale-produce-vibrazioni-la-stipsi-idiopatica-cronica/art-1_pag66_tab2/ 2023-05-02T20:29:22+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-capsula-orale-produce-vibrazioni-la-stipsi-idiopatica-cronica/art-1_pag67_desc1/ 2023-05-02T20:30:33+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-un-prodotto-base-fattore-viii-durata-dazione-piu-lunga-lemofilia/art-2_pag67_puntichiave/ 2023-05-02T20:36:43+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-un-prodotto-base-fattore-viii-durata-dazione-piu-lunga-lemofilia/art-2_pag67_tab1/ 2023-05-02T20:38:07+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-un-prodotto-base-fattore-viii-durata-dazione-piu-lunga-lemofilia/art-2_pag68_desc1/ 2023-05-02T20:41:09+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-lenacapavir-lhiv-multifarmaco-resistente/art-3_pag69_puntichiave/ 2023-05-02T20:45:33+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-lenacapavir-lhiv-multifarmaco-resistente/art-3_pag69_tab1/ 2023-05-02T20:46:49+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-lenacapavir-lhiv-multifarmaco-resistente/art-3_pag69_tab2/ 2023-05-02T20:48:36+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-lenacapavir-lhiv-multifarmaco-resistente/art-3_pag70_tab3/ 2023-05-02T20:49:35+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-lenacapavir-lhiv-multifarmaco-resistente/art-3_pag70_desc/ 2023-05-02T20:51:49+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-emulsione-oftalmica-base-ciclosporina-la-cheratocongiuntivite-vernal/art-4_pag71_puntichiave/ 2023-05-02T20:58:24+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-emulsione-oftalmica-base-ciclosporina-la-cheratocongiuntivite-vernal/art-4_pag71_desc/ 2023-05-02T21:00:49+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-emulsione-oftalmica-base-ciclosporina-la-cheratocongiuntivite-vernal/art-4_pag72_desc2/ 2023-05-02T21:01:40+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-uno-spray-nasale-banco/art-5_pag72_tab1/ 2023-05-02T21:07:30+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-uno-spray-nasale-banco/art-5_pag72_desc/ 2023-05-02T21:08:15+00:00 https://www.med-life.it/number_articles/tml-n-9-2023-uno-spray-nasale-banco/art-5_pag72_tabfinale/ 2023-05-02T21:08:52+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_73_puntichiave/ 2023-05-16T21:03:53+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_74_tab1/ 2023-05-16T21:05:26+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_75_tab2/ 2023-05-16T21:06:14+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_77_tab2/ 2023-05-16T21:14:39+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_78_tab3/ 2023-05-16T21:16:37+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_79_descr1/ 2023-05-16T21:20:54+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_79_descr2/ 2023-05-16T21:21:41+00:00 https://www.med-life.it/number_articles/tml-n-10-2023-scelta-dei-contraccettivi/art-1_pag_80_descr1/ 2023-05-16T21:22:35+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-capsule-orali-microbiota-fecale-vivo-la-prevenzione-delle-recidive-cdi/art-1_pag-81_puntichiave/ 2023-05-28T21:19:13+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-capsule-orali-microbiota-fecale-vivo-la-prevenzione-delle-recidive-cdi/art-1_pag-82_tab1/ 2023-05-28T21:22:49+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-capsule-orali-microbiota-fecale-vivo-la-prevenzione-delle-recidive-cdi/art-1_pag-82_desc/ 2023-05-28T21:24:57+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-capsule-orali-microbiota-fecale-vivo-la-prevenzione-delle-recidive-cdi/art-1_pag-83_desc2/ 2023-05-28T21:25:51+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-eflapegrastim-la-prevenzione-della-neutropenia-febbrile-indotta-dalla-chemioterapia/art-2_pag-83_tab1/ 2023-05-28T21:31:49+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-eflapegrastim-la-prevenzione-della-neutropenia-febbrile-indotta-dalla-chemioterapia/art-2_pag-83_tab2/ 2023-05-28T21:33:30+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-eflapegrastim-la-prevenzione-della-neutropenia-febbrile-indotta-dalla-chemioterapia/art-2_pag-84_puntichiave/ 2023-05-28T21:34:14+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-eflapegrastim-la-prevenzione-della-neutropenia-febbrile-indotta-dalla-chemioterapia/art-2_pag-84_desc/ 2023-05-28T21:36:39+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-cariprazina-trattamento-aggiuntivo-della-depressione/art-3_pag-84_tab1/ 2023-05-28T21:40:55+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-cariprazina-trattamento-aggiuntivo-della-depressione/art-3_pag-85_tab2/ 2023-05-28T21:41:37+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-cariprazina-trattamento-aggiuntivo-della-depressione/art-3_pag-85_tab3/ 2023-05-28T21:44:05+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-cariprazina-trattamento-aggiuntivo-della-depressione/art-2_pag-84_puntichiave-2/ 2023-05-28T21:44:50+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-cariprazina-trattamento-aggiuntivo-della-depressione/art-3_pag-86_desc/ 2023-05-28T21:46:11+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-autorizzazione-alluso-emergenza-vilobelimab-la-covid-19/art-4_pag-86_tab1/ 2023-05-28T21:51:58+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-autorizzazione-alluso-emergenza-vilobelimab-la-covid-19/art-4_pag-87_desc/ 2023-05-28T21:54:39+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-metformina-prevenire-la-long-covid/art-4_pag-88_desc/ 2023-05-28T22:00:48+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-metformina-prevenire-la-long-covid/art-4_pag-88_prossimamente/ 2023-05-28T22:01:32+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-89_punti/ 2023-06-14T20:26:41+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-89_tab1/ 2023-06-14T20:27:57+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-92_tab2/ 2023-06-14T20:38:03+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-94_tab3/ 2023-06-14T20:44:41+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-95_tab3/ 2023-06-14T20:45:29+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-95_tab4/ 2023-06-14T20:47:16+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-95_desc/ 2023-06-14T20:48:11+00:00 https://www.med-life.it/number_articles/tml-n-11-2023-farmaci-per-emicrania/art-1_pag-96_desc/ 2023-06-14T20:49:11+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-fezolinetant-sintomi-vasomotori-della-menopausa/art1_pag97_puntichiave/ 2023-06-28T21:33:48+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-fezolinetant-sintomi-vasomotori-della-menopausa/art1_pag97_tab1/ 2023-06-28T21:34:38+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-fezolinetant-sintomi-vasomotori-della-menopausa/art1_pag98_tab2/ 2023-06-28T21:35:28+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-fezolinetant-sintomi-vasomotori-della-menopausa/art1_pag99_desc/ 2023-06-28T21:37:49+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-brexpiprazolo-lagitazione-nella-demenza-alzheimer/art2_pag99_puntichiave/ 2023-06-28T21:42:32+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-brexpiprazolo-lagitazione-nella-demenza-alzheimer/art2_pag100_tab1/ 2023-06-28T21:46:07+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-brexpiprazolo-lagitazione-nella-demenza-alzheimer/art2_pag101_desc/ 2023-06-28T21:47:13+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-ampliamento-delle-indicazioni-del-dapagliflozin-linsufficienza-cardiaca/art3_pag101_tab1/ 2023-06-28T21:52:07+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-ampliamento-delle-indicazioni-del-dapagliflozin-linsufficienza-cardiaca/art3_pag101_tab2/ 2023-06-28T21:52:55+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-ampliamento-delle-indicazioni-del-dapagliflozin-linsufficienza-cardiaca/art3_pag102_desc/ 2023-06-28T21:54:22+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-alternative-al-mifepristone-laborto-farmacologico/art3_pag103_desc/ 2023-06-28T21:59:40+00:00 https://www.med-life.it/number_articles/tml-n-13-2023-ivermectina-banco-pidocchi/art4_pag103_desc2/ 2023-06-28T22:03:55+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-105_puntichiave/ 2023-07-08T19:48:22+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-106_tab1/ 2023-07-08T19:49:42+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-107_tab2/ 2023-07-08T19:52:16+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-110_tab3/ 2023-07-08T20:02:52+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-111_tab3/ 2023-07-08T20:03:50+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-111_desc/ 2023-07-08T20:04:37+00:00 https://www.med-life.it/number_articles/tml-n-14-2023-farmaci-le-malattie-infiammatorie-intestinali/art-1_pag-112_desc/ 2023-07-08T20:05:23+00:00 https://www.med-life.it/number_articles/ad-n-2732023-rischio-sedazione-prolungata-luso-del-clordiazepossido-nel-trattamento-dellastinenza-alcool/tab_1_ad273/ 2023-07-15T16:38:40+00:00 https://www.med-life.it/number_articles/ad-n-2732023-rischio-sedazione-prolungata-luso-del-clordiazepossido-nel-trattamento-dellastinenza-alcool/tab_2_ad273/ 2023-07-15T16:40:53+00:00 https://www.med-life.it/number_articles/ad-n-2732023-rischio-sedazione-prolungata-luso-del-clordiazepossido-nel-trattamento-dellastinenza-alcool/bibliografia_ad273/ 2023-07-15T16:44:42+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-tofersen-la-sla/art-1_pag-113_puntichiave/ 2023-07-24T22:48:00+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-tofersen-la-sla/art-1_pag-114_tab1/ 2023-07-24T22:49:15+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-tofersen-la-sla/art-1_pag-114_desc/ 2023-07-24T22:51:31+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-sotagliflozin-linsufficienza-cardiaca/art-2_pag-115_tab1/ 2023-07-24T22:57:16+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-sotagliflozin-linsufficienza-cardiaca/art-2_pag-115_tab2/ 2023-07-24T22:59:16+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-sotagliflozin-linsufficienza-cardiaca/art-2_pag-116_tab3/ 2023-07-24T23:00:29+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-sotagliflozin-linsufficienza-cardiaca/art-2_pag-116_puntichiave/ 2023-07-24T23:01:57+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-sotagliflozin-linsufficienza-cardiaca/art-2_pag-116_desc/ 2023-07-24T23:02:50+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-zavegepant-trattamento-acuto-dellemicrania/art-3_pag-117_tab1/ 2023-07-24T23:09:39+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-zavegepant-trattamento-acuto-dellemicrania/art-3_pag-117_tab2/ 2023-07-24T23:11:28+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-zavegepant-trattamento-acuto-dellemicrania/art-3_pag-118_puntichiave/ 2023-07-24T23:13:45+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-zavegepant-trattamento-acuto-dellemicrania/art-3_pag-118_desc/ 2023-07-24T23:14:37+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-inspire-lapnea-ostruttiva-del-sonno/art-4_pag-119_puntichiave/ 2023-07-24T23:20:26+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-inspire-lapnea-ostruttiva-del-sonno/art-4_pag-119_tab1/ 2023-07-24T23:22:29+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-inspire-lapnea-ostruttiva-del-sonno/art-4_pag-120_desc/ 2023-07-24T23:24:38+00:00 https://www.med-life.it/number_articles/tml-n-15-2023-inspire-lapnea-ostruttiva-del-sonno/art-4_pag-120_desc2/ 2023-07-24T23:26:08+00:00 https://www.med-life.it/?attachment_id=28690 2023-07-27T21:08:30+00:00 https://www.med-life.it/number_articles/tml-n-16-2023-farmaci-disturbi-dansia/art-1_pag121_puntichiave/ 2023-08-08T09:00:40+00:00 https://www.med-life.it/number_articles/tml-n-16-2023-farmaci-disturbi-dansia/art-1_pag122_tab1/ 2023-08-08T09:03:01+00:00 https://www.med-life.it/number_articles/tml-n-16-2023-farmaci-disturbi-dansia/art-1_pag123_tab2/ 2023-08-08T09:03:53+00:00 https://www.med-life.it/number_articles/tml-n-16-2023-farmaci-disturbi-dansia/art-1_pag125_tab3/ 2023-08-08T09:08:26+00:00 https://www.med-life.it/number_articles/tml-n-16-2023-farmaci-disturbi-dansia/art-2_pag127_descr/ 2023-08-08T09:18:29+00:00 https://www.med-life.it/number_articles/tml-n-16-2023-farmaci-disturbi-dansia/art-2_pag128_descr/ 2023-08-08T09:19:24+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-lecanemab-ottenuto-la-piena-approvazione-la-malattia-alzheimer-fase-iniziale/art-1_pag129_puntichiave/ 2023-08-19T16:52:09+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-lecanemab-ottenuto-la-piena-approvazione-la-malattia-alzheimer-fase-iniziale/art-1_pag130_descr/ 2023-08-19T16:53:17+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-bexagliflozin-un-quinto-inibitore-dell-sglt2-diabete-tipo-2/art-2_pag130_tab1/ 2023-08-19T16:59:25+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-bexagliflozin-un-quinto-inibitore-dell-sglt2-diabete-tipo-2/art-2_pag131_tab2/ 2023-08-19T17:00:36+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-bexagliflozin-un-quinto-inibitore-dell-sglt2-diabete-tipo-2/art-2_pag131_tab3/ 2023-08-19T17:01:38+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-bexagliflozin-un-quinto-inibitore-dell-sglt2-diabete-tipo-2/art-2_pag132_tab4/ 2023-08-19T17:03:01+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-bexagliflozin-un-quinto-inibitore-dell-sglt2-diabete-tipo-2/art-2_pag132_puntichiave/ 2023-08-19T17:04:26+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-bexagliflozin-un-quinto-inibitore-dell-sglt2-diabete-tipo-2/art-2_pag132_descr/ 2023-08-19T17:05:51+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-buprenorfina-sottocutanea-volta-alla-settimana-volta-al-mese-disturbo-uso-oppioidi/art-3_pag133_tab1/ 2023-08-19T17:11:21+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-buprenorfina-sottocutanea-volta-alla-settimana-volta-al-mese-disturbo-uso-oppioidi/art-3_pag133_puntichiave/ 2023-08-19T17:12:11+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-buprenorfina-sottocutanea-volta-alla-settimana-volta-al-mese-disturbo-uso-oppioidi/art-3_pag133_tab2/ 2023-08-19T17:15:37+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-buprenorfina-sottocutanea-volta-alla-settimana-volta-al-mese-disturbo-uso-oppioidi/art-3_pag134_tab3/ 2023-08-19T17:16:32+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-buprenorfina-sottocutanea-volta-alla-settimana-volta-al-mese-disturbo-uso-oppioidi/art-3_pag135_desc/ 2023-08-19T17:18:47+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-linaclotide-la-stipsi-funzionale/art-4_pag135_tab1/ 2023-08-19T17:24:11+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-linaclotide-la-stipsi-funzionale/art-4_pag136_puntichiave/ 2023-08-19T17:25:46+00:00 https://www.med-life.it/number_articles/tml-n-17-2023-linaclotide-la-stipsi-funzionale/art-4_pag136_desc/ 2023-08-19T17:26:39+00:00 https://www.med-life.it/number_articles/ad-n-2742023-sicurezza-della-lattazione-indotta-farmacologicamente/biblio_1-2/ 2023-09-01T20:42:10+00:00 https://www.med-life.it/number_articles/ad-n-2742023-sicurezza-della-lattazione-indotta-farmacologicamente/bublio2/ 2023-09-01T20:42:29+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-137_puntichiave/ 2023-09-03T17:27:44+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-138_tab1/ 2023-09-03T17:29:03+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-140_tab2/ 2023-09-03T17:33:01+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-141_tab3/ 2023-09-03T17:39:11+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-142_tab4/ 2023-09-03T17:39:59+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-143_desc/ 2023-09-03T17:43:04+00:00 https://www.med-life.it/number_articles/tml-n-18-2023-farmaci-disturbo-uso-oppioidi/art-1_pag-144_desc/ 2023-09-03T17:43:25+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-nirsevimab-la-prevenzione-della-malattia-vrs-grave-nei-bambini-piccoli/art-1_pag-145_puntichiave/ 2023-09-16T13:57:19+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-nirsevimab-la-prevenzione-della-malattia-vrs-grave-nei-bambini-piccoli/art-1_pag-146_tab1/ 2023-09-16T13:59:35+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-nirsevimab-la-prevenzione-della-malattia-vrs-grave-nei-bambini-piccoli/art-1_pag-146_tab2/ 2023-09-16T14:01:06+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-nirsevimab-la-prevenzione-della-malattia-vrs-grave-nei-bambini-piccoli/art-1_pag-147_tab3/ 2023-09-16T14:03:09+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-nirsevimab-la-prevenzione-della-malattia-vrs-grave-nei-bambini-piccoli/art-1_pag-147_desc/ 2023-09-16T14:04:01+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-preparazione-basso-volume-colonscopia/art-2_pag-148_puntichiave/ 2023-09-16T14:10:11+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-preparazione-basso-volume-colonscopia/art-2_pag-148_tab1/ 2023-09-16T14:10:41+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-preparazione-basso-volume-colonscopia/art-2_pag-149_tab2/ 2023-09-16T14:13:07+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-preparazione-basso-volume-colonscopia/art-2_pag-150_desc/ 2023-09-16T14:14:30+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-un-contraccettivo-orale-banco/art-3_pag-150_puntichiave/ 2023-09-16T14:19:19+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-un-contraccettivo-orale-banco/art-3_pag-151_desc/ 2023-09-16T14:21:28+00:00 https://www.med-life.it/number_articles/tml-n-19-2023-un-contraccettivo-orale-banco/art-3_pag-151_prossimamente/ 2023-09-16T14:21:50+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-due-vaccini-la-prevenzione-della-malattia-rsv/art-1_pag-153_puntichiave/ 2023-10-01T21:07:29+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-due-vaccini-la-prevenzione-della-malattia-rsv/art-1_pag-154_tab1/ 2023-10-01T21:08:20+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-due-vaccini-la-prevenzione-della-malattia-rsv/art-1_pag-154_tab2/ 2023-10-01T21:10:40+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-due-vaccini-la-prevenzione-della-malattia-rsv/art-1_pag-155_tab3/ 2023-10-01T21:21:05+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-due-vaccini-la-prevenzione-della-malattia-rsv/art-1_pag-155_tab4/ 2023-10-01T21:22:19+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-due-vaccini-la-prevenzione-della-malattia-rsv/art-1_pag-156_desc/ 2023-10-01T21:24:37+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-colchicina-basso-dosaggio-la-prevenzione-degli-eventi-cardiovascolari/art-2_pag-156_puntichiave/ 2023-10-01T21:31:46+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-colchicina-basso-dosaggio-la-prevenzione-degli-eventi-cardiovascolari/art-2_pag-156_tab1/ 2023-10-01T21:32:18+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-colchicina-basso-dosaggio-la-prevenzione-degli-eventi-cardiovascolari/art-2_pag-157_desc/ 2023-10-01T21:34:15+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-valoctocogene-roxaparvovec-terapia-genica-lemofilia-grave/art-3_pag-157_frase/ 2023-10-01T21:37:41+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-valoctocogene-roxaparvovec-terapia-genica-lemofilia-grave/art-3_pag-158_puntichiave/ 2023-10-01T21:40:37+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-valoctocogene-roxaparvovec-terapia-genica-lemofilia-grave/art-3_pag-158_desc/ 2023-10-01T21:42:06+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-delandistrogene-moxeparvovec-la-distrofia-muscolare-duchenne/art-3_pag-158_puntichiave-2/ 2023-10-01T21:45:46+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-delandistrogene-moxeparvovec-la-distrofia-muscolare-duchenne/art-4_pag-159_puntichiave/ 2023-10-01T21:48:18+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-delandistrogene-moxeparvovec-la-distrofia-muscolare-duchenne/art-4pag-158_frase/ 2023-10-01T21:50:20+00:00 https://www.med-life.it/number_articles/tml-n-20-2023-delandistrogene-moxeparvovec-la-distrofia-muscolare-duchenne/art-4_pag-159_desc/ 2023-10-01T21:51:41+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-vaccino-antinfluenzale-2023-2024/art1_pag-161_puntichiave/ 2023-10-12T21:10:07+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-vaccino-antinfluenzale-2023-2024/art1_pag-161_tab1/ 2023-10-12T21:10:24+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-vaccino-antinfluenzale-2023-2024/art1_pag-163_tab2/ 2023-10-12T21:14:24+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-vaccino-antinfluenzale-2023-2024/art1_pag-165_desc/ 2023-10-12T21:21:16+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-vaccino-antinfluenzale-2023-2024/art1_pag-166_desc/ 2023-10-12T21:22:04+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-nalmefene-spray-nasale-linversione-del-sovradosaggio-oppioidi/art2_pag-166_puntichiave/ 2023-10-12T21:30:47+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-nalmefene-spray-nasale-linversione-del-sovradosaggio-oppioidi/art2_pag-166_tab1/ 2023-10-12T21:31:05+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-nalmefene-spray-nasale-linversione-del-sovradosaggio-oppioidi/art2_pag-166_tab2/ 2023-10-12T21:32:40+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-nalmefene-spray-nasale-linversione-del-sovradosaggio-oppioidi/art2_pag-167_desc/ 2023-10-12T21:34:16+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-nuove-formulazioni-dei-vaccini-pfizer-moderna-2023-2024/art2_pag-168_tab1/ 2023-10-12T21:38:13+00:00 https://www.med-life.it/number_articles/tml-n-21-2023-nuove-formulazioni-dei-vaccini-pfizer-moderna-2023-2024/art2_pag-168_desc/ 2023-10-12T21:39:17+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-farmaci-la-gotta/art-1_pag-169_puntichiave/ 2023-10-28T14:25:00+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-farmaci-la-gotta/art-1_pag-171_tab1/ 2023-10-28T14:29:43+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-farmaci-la-gotta/art-1_pag-174_desc1/ 2023-10-28T14:38:46+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-farmaci-la-gotta/art-1_pag-174_desc2/ 2023-10-28T14:39:03+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-farmaci-la-gotta/art-1_pag-175_desc3/ 2023-10-28T14:39:21+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-un-esame-del-sangue-la-malattia-alzheimer/art-2_pag-175_puntichiave/ 2023-10-28T14:51:11+00:00 https://www.med-life.it/number_articles/tml-n-22-2023-un-esame-del-sangue-la-malattia-alzheimer/art-2_pag-176_desc/ 2023-10-28T14:53:25+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-farmaci-antivirali-linfluenza-stagionale-2023-2024/art-1_pag-177_tab1/ 2023-11-11T17:48:31+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-farmaci-antivirali-linfluenza-stagionale-2023-2024/art-1_pag-178_tab2/ 2023-11-11T17:49:54+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-farmaci-antivirali-linfluenza-stagionale-2023-2024/art-1_pag-180_desc/ 2023-11-11T17:55:05+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-farmaci-antivirali-linfluenza-stagionale-2023-2024/art-1_pag-181_desc2/ 2023-11-11T17:56:05+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-nuova-formulazione-del-vaccino-novavax-2023-2024/art-2_pag-182_tab1/ 2023-11-11T18:14:53+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-nuova-formulazione-del-vaccino-novavax-2023-2024/art-2_pag-183_desc/ 2023-11-11T18:16:20+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-empagliflozin-la-malattia-renale-cronica/art-3_pag-183_tab1/ 2023-11-11T18:20:53+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-empagliflozin-la-malattia-renale-cronica/art-3_pag-183_tab2/ 2023-11-11T18:23:15+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-empagliflozin-la-malattia-renale-cronica/art-3_pag-184_tab3/ 2023-11-11T18:24:41+00:00 https://www.med-life.it/number_articles/tml-n-23-2023-empagliflozin-la-malattia-renale-cronica/art-3_pag-184_desc/ 2023-11-11T18:26:21+00:00 https://www.med-life.it/number_articles/ad-n-2752023-levoluzione-della-farmacovigilanza-contributo-michael-d-rawlins/tab_1-ad275/ 2023-11-26T15:17:35+00:00 https://www.med-life.it/number_articles/ad-n-2752023-levoluzione-della-farmacovigilanza-contributo-michael-d-rawlins/desc-ad275/ 2023-11-26T15:22:50+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-ritlecitinib-lalopecia-areata-grave/art-1_pag185_puntichiave/ 2023-11-26T16:14:38+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-ritlecitinib-lalopecia-areata-grave/art-1_pag185_tab1/ 2023-11-26T16:14:53+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-ritlecitinib-lalopecia-areata-grave/art-1_pag186_desc/ 2023-11-26T16:18:14+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-etrasimod-la-colite-ulcerosa/art-2_pag187_puntichiave/ 2023-11-26T16:24:44+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-etrasimod-la-colite-ulcerosa/art-2_pag187_tab1/ 2023-11-26T16:25:04+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-etrasimod-la-colite-ulcerosa/art-2_pag188_desc/ 2023-11-26T16:27:42+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-associazione-sulbactamdurlobactam-la-polmonite-acinetobacter/art-3_pag188_tab1/ 2023-11-26T16:31:09+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-associazione-sulbactamdurlobactam-la-polmonite-acinetobacter/art-3_pag189_puntichiave/ 2023-11-26T16:31:23+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-associazione-sulbactamdurlobactam-la-polmonite-acinetobacter/art-3_pag189_desc/ 2023-11-26T16:34:32+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-terapia-onde-durto-la-disfunzione-erettile/art-4_pag190_desc/ 2023-11-26T16:38:46+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-effetti-gastrointestinali-degli-agonisti-del-recettore-del-glp-1/art-5_pag191_tab1/ 2023-11-26T16:42:09+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-effetti-gastrointestinali-degli-agonisti-del-recettore-del-glp-1/art-5_pag191_desc/ 2023-11-26T16:43:56+00:00 https://www.med-life.it/number_articles/tml-n-24-2023-addendum/tml_24-2023_1690-web_w-2/ 2023-11-26T16:47:11+00:00 https://www.med-life.it/number_articles/tml-n-25-2023-farmaci-la-depressione/puntichiave_pag-193/ 2023-12-08T15:53:07+00:00 https://www.med-life.it/number_articles/tml-n-25-2023-farmaci-la-depressione/tab1_pag-196/ 2023-12-08T16:04:46+00:00 https://www.med-life.it/number_articles/tml-n-25-2023-farmaci-la-depressione/tab1_pag-197/ 2023-12-08T16:05:03+00:00 https://www.med-life.it/number_articles/tml-n-25-2023-farmaci-la-depressione/desc_pag-199/ 2023-12-08T16:15:15+00:00 https://www.med-life.it/number_articles/tml-n-25-2023-farmaci-la-depressione/desc_pag-200/ 2023-12-08T16:15:30+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-un-farmaco-orale-la-depressione-post-partum/art-1_pag-201_puntichiave/ 2023-12-27T21:38:15+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-un-farmaco-orale-la-depressione-post-partum/art-1_pag-201_tab1/ 2023-12-27T21:38:29+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-un-farmaco-orale-la-depressione-post-partum/art-1_pag-202_tab2/ 2023-12-27T21:40:49+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-un-farmaco-orale-la-depressione-post-partum/art-1_pag-203_desc/ 2023-12-27T21:43:20+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-vonoprazan-lesofagite-erosiva/art-2_pag-203_tab1/ 2023-12-27T21:50:58+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-vonoprazan-lesofagite-erosiva/art-2_pag-204_puntichiave/ 2023-12-27T21:51:43+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-vonoprazan-lesofagite-erosiva/art-2_pag-204_descr/ 2023-12-27T21:53:53+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-vonoprazan-lesofagite-erosiva/art-2_pag-205_descr/ 2023-12-27T21:54:10+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tirzepatide-la-gestione-cronica-del-peso/art-3_pag-205_tab1/ 2023-12-27T22:01:49+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tirzepatide-la-gestione-cronica-del-peso/art-3_pag-205_tab2/ 2023-12-27T22:03:09+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tirzepatide-la-gestione-cronica-del-peso/art-3_pag-206_tab3/ 2023-12-27T22:04:27+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tirzepatide-la-gestione-cronica-del-peso/art-3_pag-206_puntichiave/ 2023-12-27T22:06:30+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tirzepatide-la-gestione-cronica-del-peso/art-3_pag-207_descr/ 2023-12-27T22:07:24+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tre-nuovi-farmaci-antipsicotici-iniettabili/art-4_pag-207_tab1/ 2023-12-27T22:12:05+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tre-nuovi-farmaci-antipsicotici-iniettabili/art-4_pag-208_buone-feste/ 2023-12-27T22:13:26+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tre-nuovi-farmaci-antipsicotici-iniettabili/art-4_pag-208_descr/ 2023-12-27T22:13:42+00:00 https://www.med-life.it/number_articles/tml-n-26-2023-tre-nuovi-farmaci-antipsicotici-iniettabili/art-4_pag-208_prossimamente/ 2023-12-27T22:13:57+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab1_pag-1/ 2024-01-06T21:18:48+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab1_puntichiave/ 2024-01-06T21:21:14+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab2_pag-2/ 2024-01-06T21:22:44+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab3_pag2/ 2024-01-06T21:26:35+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab4_pag5/ 2024-01-06T21:32:05+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab5_pag6/ 2024-01-06T21:35:08+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_tab5_pag7/ 2024-01-06T21:35:27+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_desc_pag8/ 2024-01-06T21:37:38+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_desc2_pag8/ 2024-01-06T21:38:21+00:00 https://www.med-life.it/number_articles/tml-n-1-2024-trattamento-della-fibrillazione-atriale/art-1_prossimamente_pag8/ 2024-01-06T21:38:41+00:00 https://www.med-life.it/?attachment_id=21345 2024-01-16T16:27:27+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-due-terapie-geniche-lanemia-falciforme/art-1_pag-9_puntichiave/ 2024-01-21T15:11:58+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-due-terapie-geniche-lanemia-falciforme/art-1_pag-10_desc/ 2024-01-21T15:12:37+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-bimekizumab-la-psoriasi/art-2_pag-11_puntichiave/ 2024-01-21T15:16:14+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-bimekizumab-la-psoriasi/art-2_pag-12_tab1/ 2024-01-21T15:20:34+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-bimekizumab-la-psoriasi/art-2_pag-12_tab2/ 2024-01-21T15:21:21+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-bimekizumab-la-psoriasi/art-2_pag-13_desc/ 2024-01-21T15:22:32+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-soluzione-oftalmica-perfluoroesilottano-la-malattia-dellocchio-secco/art-3_pag-13_puntichiave/ 2024-01-21T15:27:23+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-soluzione-oftalmica-perfluoroesilottano-la-malattia-dellocchio-secco/art-3_pag-14_tab1/ 2024-01-21T15:29:24+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-soluzione-oftalmica-perfluoroesilottano-la-malattia-dellocchio-secco/art-3_pag-14_desc/ 2024-01-21T15:31:05+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-avacincaptad-pegol-latrofia-geografica-nella-degenerazione-maculare-senile/art-5_pag-15_tab1/ 2024-01-21T15:35:55+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-avacincaptad-pegol-latrofia-geografica-nella-degenerazione-maculare-senile/art-5_pag-15_puntichiave/ 2024-01-21T15:36:34+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-avacincaptad-pegol-latrofia-geografica-nella-degenerazione-maculare-senile/art-5_pag-15_tab2/ 2024-01-21T15:37:31+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-avacincaptad-pegol-latrofia-geografica-nella-degenerazione-maculare-senile/art-5_pag-15_desc/ 2024-01-21T15:38:20+00:00 https://www.med-life.it/number_articles/tml-n-2-2024-avacincaptad-pegol-latrofia-geografica-nella-degenerazione-maculare-senile/art-5_pag-16_desc/ 2024-01-21T15:38:58+00:00 https://www.med-life.it/number_articles/ad-n-2762023-risvolti-terapeutici-nascono-reazioni-avverse-ai-farmaci/tab-2/ 2024-01-23T21:57:55+00:00 https://www.med-life.it/number_articles/ad-n-2762023-risvolti-terapeutici-nascono-reazioni-avverse-ai-farmaci/tab-1/ 2024-01-23T21:58:15+00:00 https://www.med-life.it/number_articles/ad-n-2762023-risvolti-terapeutici-nascono-reazioni-avverse-ai-farmaci/biblio-2/ 2024-01-23T21:59:27+00:00 https://www.med-life.it/number_articles/ad-n-2762023-risvolti-terapeutici-nascono-reazioni-avverse-ai-farmaci/biblio-1/ 2024-01-23T21:59:27+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-lacne/art-1_pag17_puntichiave/ 2024-02-04T07:34:51+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-lacne/art-1_pag18_tab1/ 2024-02-04T07:36:49+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-lacne/art-1_pag19_tab2/ 2024-02-04T07:38:13+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-lacne/art-1_pag20_desc/ 2024-02-04T07:43:20+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-lacne/art-1_pag20_desc-2/ 2024-02-04T07:43:33+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-lacne/art-1_pag20_desc-3/ 2024-02-04T07:44:45+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-la-rosacea/art-2_pag21_puntichiave/ 2024-02-04T08:23:03+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-la-rosacea/art-2_pag21_tab1/ 2024-02-04T08:25:15+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-farmaci-la-rosacea/art-1_pag22_desc/ 2024-02-04T08:27:35+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-carbossimaltosio-ferrico-iniettabile-la-carenza-ferro-nellinsufficienza-cardiaca/art-3_pag23_puntichiave/ 2024-02-04T08:36:56+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-carbossimaltosio-ferrico-iniettabile-la-carenza-ferro-nellinsufficienza-cardiaca/art-3_pag23_tab1/ 2024-02-04T08:38:05+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-carbossimaltosio-ferrico-iniettabile-la-carenza-ferro-nellinsufficienza-cardiaca/art-3_pag23_tab2/ 2024-02-04T08:39:02+00:00 https://www.med-life.it/number_articles/tml-n-3-2024-carbossimaltosio-ferrico-iniettabile-la-carenza-ferro-nellinsufficienza-cardiaca/art-3_pag23_desc/ 2024-02-04T08:40:10+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-daprodustat-lanemia-pazienti-insufficienza-renale-cronica/art1_pag25_tab1/ 2024-02-11T07:59:15+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-daprodustat-lanemia-pazienti-insufficienza-renale-cronica/art1_pag25_puntichiave/ 2024-02-11T08:00:01+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-daprodustat-lanemia-pazienti-insufficienza-renale-cronica/art1_pag26_tab2/ 2024-02-11T08:01:41+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-daprodustat-lanemia-pazienti-insufficienza-renale-cronica/art1_pag26_tab3/ 2024-02-11T08:02:37+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-daprodustat-lanemia-pazienti-insufficienza-renale-cronica/art_1_desc/ 2024-02-11T08:25:59+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-soluzione-topica-cantaridina-mollusco-contagioso/art2_pag28_puntichiave/ 2024-02-12T21:12:55+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-soluzione-topica-cantaridina-mollusco-contagioso/art2_pag28_desc/ 2024-02-12T21:15:08+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-rozanolixizumab-la-miastenia-grave/art3_pag29_puntichiave/ 2024-02-12T21:19:03+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-rozanolixizumab-la-miastenia-grave/art3_pag29_tab1/ 2024-02-12T21:20:26+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-rozanolixizumab-la-miastenia-grave/art3_pag29_tab2/ 2024-02-12T21:21:22+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-rozanolixizumab-la-miastenia-grave/art3_pag30_tab3/ 2024-02-12T21:22:43+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-rozanolixizumab-la-miastenia-grave/art3_pag30_desc/ 2024-02-12T21:24:16+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-un-altro-pcc-quattro-fattori-linversione-del-warfarin/art4_pag31_puntichiave/ 2024-02-12T21:30:05+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-un-altro-pcc-quattro-fattori-linversione-del-warfarin/desc-art4-2/ 2024-02-12T21:33:23+00:00 https://www.med-life.it/number_articles/tml-n-4-2024-un-altro-pcc-quattro-fattori-linversione-del-warfarin/desc-art4-1/ 2024-02-12T21:33:52+00:00 https://www.med-life.it/number_articles/ad-n-2772024-un-esito-fatale-dovuto-somministrazione-continua-gentamicina-un-caso-clinico/biblio_1-3/ 2024-02-26T23:59:21+00:00 https://www.med-life.it/number_articles/ad-n-2772024-un-esito-fatale-dovuto-somministrazione-continua-gentamicina-un-caso-clinico/biblio_2-3/ 2024-02-26T23:59:41+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-farmaci-sintomi-della-menopausa/art-1_pag33_puntichiave/ 2024-02-27T21:36:02+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-farmaci-sintomi-della-menopausa/art-1_pag34_tab1/ 2024-02-27T21:37:00+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-farmaci-sintomi-della-menopausa/art-1_pag35_tab2/ 2024-02-27T21:39:27+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-farmaci-sintomi-della-menopausa/art-1_pag37_desc1/ 2024-02-27T21:44:11+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-farmaci-sintomi-della-menopausa/art-1_pag37_desc2/ 2024-02-27T21:44:21+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-farmaci-sintomi-della-menopausa/art-1_pag38_desc3/ 2024-02-27T21:44:36+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-tenapanor-liperfosfatemia-nellinsufficienza-renale-cronica/art-2_pag38_puntichiave/ 2024-02-27T22:07:15+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-tenapanor-liperfosfatemia-nellinsufficienza-renale-cronica/art-2_pag38_tab1/ 2024-02-27T22:07:42+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-tenapanor-liperfosfatemia-nellinsufficienza-renale-cronica/art-2_pag39_tab2/ 2024-02-27T22:09:35+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-tenapanor-liperfosfatemia-nellinsufficienza-renale-cronica/art-2_pag39_desc/ 2024-02-27T22:11:30+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-ipocalcemia-grave-denosumab-nella-malattia-renale-cronica/art-2_pag40_desc/ 2024-02-27T22:17:27+00:00 https://www.med-life.it/number_articles/tml-n-5-2024-ipocalcemia-grave-denosumab-nella-malattia-renale-cronica/art-2_pag40_tab1/ 2024-02-27T22:17:40+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-unassociazione-salbutamolo-budesonide-via-inalatoria-lasma/art-1_pag-41_puntichiave/ 2024-03-16T11:14:52+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-unassociazione-salbutamolo-budesonide-via-inalatoria-lasma/art-1_pag-41_puntichiave-2/ 2024-03-16T11:15:18+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-unassociazione-salbutamolo-budesonide-via-inalatoria-lasma/art-1_pag-42_tab1/ 2024-03-16T11:16:04+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-unassociazione-salbutamolo-budesonide-via-inalatoria-lasma/art-1_pag-43_descr1/ 2024-03-16T11:19:09+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-unassociazione-salbutamolo-budesonide-via-inalatoria-lasma/art-1_pag-43_descr2/ 2024-03-16T11:19:27+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-un-vaccino-meningococcico-pentavalente/art-2_pag-44_tab1/ 2024-03-16T11:27:14+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-un-vaccino-meningococcico-pentavalente/art-2_pag-44_tab2/ 2024-03-16T11:28:41+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-un-vaccino-meningococcico-pentavalente/art-2_pag-45_puntichiave/ 2024-03-16T11:29:33+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-un-vaccino-meningococcico-pentavalente/art-2_pag-45_desc/ 2024-03-16T11:31:26+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-mirikizumab-la-colite-ulcerosa/art-3_pag-46_puntichiave/ 2024-03-16T11:45:42+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-mirikizumab-la-colite-ulcerosa/art-3_pag-46_tab1/ 2024-03-16T11:46:01+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-mirikizumab-la-colite-ulcerosa/art-3_pag-47_tab2/ 2024-03-16T11:48:07+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-mirikizumab-la-colite-ulcerosa/art-3_pag-47_descr1/ 2024-03-16T11:49:04+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-mirikizumab-la-colite-ulcerosa/art-3_pag-47_descr2/ 2024-03-16T11:49:21+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-un-spray-nasale-al-naloxone-banco/art-3_pag-48_tab1/ 2024-03-16T11:57:39+00:00 https://www.med-life.it/number_articles/tml-n-6-2024-un-spray-nasale-al-naloxone-banco/art-3_pag-48_descr/ 2024-03-16T11:58:22+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-49_puntichiave/ 2024-04-02T21:20:10+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-50_tab1/ 2024-04-02T21:20:26+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-51_tab1/ 2024-04-02T21:22:42+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-52_tab2/ 2024-04-02T21:22:59+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-52_tab3/ 2024-04-02T21:24:25+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-53_tab4/ 2024-04-02T21:24:39+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-53_tab5/ 2024-04-02T21:26:21+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-farmaci-disturbo-bipolare/art-1_pag-54_desc/ 2024-04-02T21:27:36+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-omalizumab-le-allergie-alimentari/art-2_pag-55_puntichiave/ 2024-04-02T21:40:52+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-omalizumab-le-allergie-alimentari/art-2_pag-55_tab1/ 2024-04-02T21:41:11+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-omalizumab-le-allergie-alimentari/art-2_pag-56_desc/ 2024-04-02T21:42:58+00:00 https://www.med-life.it/number_articles/tml-n-7-2024-sicurezza-del-bupropione-gravidanza/art-2_pag-56_desc2/ 2024-04-02T21:48:46+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-roflumilast-schiuma-la-dermatite-seborroica/art-1_pag-57_tab1/ 2024-04-11T22:17:10+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-roflumilast-schiuma-la-dermatite-seborroica/art-1_pag-57_tab2/ 2024-04-11T22:17:11+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-roflumilast-schiuma-la-dermatite-seborroica/art-1_pag-58_puntichiave/ 2024-04-11T22:18:28+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-roflumilast-schiuma-la-dermatite-seborroica/art-1_pag-58_tab3/ 2024-04-11T22:19:02+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-roflumilast-schiuma-la-dermatite-seborroica/art-1_pag-59_desc/ 2024-04-11T22:20:41+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-roflumilast-schiuma-la-dermatite-seborroica/art-1_pag-59_desc2/ 2024-04-11T22:20:43+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-un-gel-tre-farmaci-lacne/art-2_pag-59_puntichiave/ 2024-04-11T22:28:17+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-un-gel-tre-farmaci-lacne/art-2_pag-60_tab1/ 2024-04-11T22:28:19+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-un-gel-tre-farmaci-lacne/art-2_pag-60_tab2/ 2024-04-11T22:29:51+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-un-gel-tre-farmaci-lacne/art-2_pag-61_desc/ 2024-04-11T22:31:19+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-zilucoplan-la-miastenia-grave/art-3_pag-61_puntichiave/ 2024-04-11T22:40:09+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-zilucoplan-la-miastenia-grave/art-3_pag-61_tab1/ 2024-04-11T22:40:11+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-zilucoplan-la-miastenia-grave/art-3_pag-62_tab2/ 2024-04-11T22:42:15+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-zilucoplan-la-miastenia-grave/art-3_pag-62_tab3/ 2024-04-11T22:43:21+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-zilucoplan-la-miastenia-grave/art-3_pag-62_desc/ 2024-04-11T22:44:40+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-zilucoplan-la-miastenia-grave/art-3_pag-63_desc/ 2024-04-11T22:44:41+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-donislecel-diabete-tipo-1/art-4_pag-64_desc/ 2024-04-11T22:54:10+00:00 https://www.med-life.it/number_articles/tml-n-8-2024-donislecel-diabete-tipo-1/art-4_pag-63_puntichiave/ 2024-04-11T22:54:53+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-resmetirom-la-steatoepatite-associata-disfunzione-metabolica/art-1_tab1_pag-65/ 2024-05-01T21:19:48+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-resmetirom-la-steatoepatite-associata-disfunzione-metabolica/art-1_puntichiave_pag-65/ 2024-05-01T21:20:28+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-resmetirom-la-steatoepatite-associata-disfunzione-metabolica/art-1_descr_pag-66/ 2024-05-01T21:22:13+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-nuova-indicazione-la-semaglutide/art-2_tab1_pag-67/ 2024-05-01T21:27:31+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-nuova-indicazione-la-semaglutide/art-2_descr_pag-67/ 2024-05-01T21:29:25+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-paracetamoloibuprofene-via-endovenosa/art-3_tab1_pag-68/ 2024-05-01T21:36:26+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-paracetamoloibuprofene-via-endovenosa/art-3_puntichiave_pag-68/ 2024-05-01T21:37:14+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-paracetamoloibuprofene-via-endovenosa/art-3_descr_pag-69/ 2024-05-01T21:38:55+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-un-impianto-base-travoprost-glaucoma/art-4_puntichiave_pag-70/ 2024-05-01T21:43:06+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-un-impianto-base-travoprost-glaucoma/art-4_descr_pag-71/ 2024-05-01T21:44:20+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-profilassi-antibiotica-le-procedure-odontoiatriche/art-5_tab1_pag-71/ 2024-05-01T21:54:25+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-profilassi-antibiotica-le-procedure-odontoiatriche/art-5_descr_pag-72/ 2024-05-01T21:55:45+00:00 https://www.med-life.it/number_articles/tml-n-9-2024-profilassi-antibiotica-le-procedure-odontoiatriche/art-5_tab2_pag-72/ 2024-05-01T21:56:38+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sotatercept-lipertensione-arteriosa-polmonare/art-1_puntichiave_pag73/ 2024-05-12T21:46:24+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sotatercept-lipertensione-arteriosa-polmonare/art-1_tab1_pag73/ 2024-05-12T21:46:57+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sotatercept-lipertensione-arteriosa-polmonare/art-1_tab2_pag73/ 2024-05-12T21:47:24+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sotatercept-lipertensione-arteriosa-polmonare/art-1_tab3_pag74/ 2024-05-12T21:47:51+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sotatercept-lipertensione-arteriosa-polmonare/art-1_descr1_pag75/ 2024-05-12T21:50:07+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sotatercept-lipertensione-arteriosa-polmonare/art-1_descr2_pag75/ 2024-05-12T21:50:08+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-nuova-indicazione-lacido-bempedoico/art-2_tab1_pag76/ 2024-05-12T21:58:10+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-nuova-indicazione-lacido-bempedoico/art-2_descr_pag76/ 2024-05-12T21:59:37+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-nuova-indicazione-lacido-bempedoico/art-2_descr2_pag77/ 2024-05-12T21:59:39+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sarilumab-la-polimialgia-reumatica/art-3_puntichiave_pag77/ 2024-05-12T22:03:44+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sarilumab-la-polimialgia-reumatica/art-3_tab1_pag77/ 2024-05-12T22:03:45+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-sarilumab-la-polimialgia-reumatica/art-3_descr_pag78/ 2024-05-12T22:06:52+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-exagamglogene-autotemcel-la-beta-talassemia/art-3_descr_pag79/ 2024-05-12T22:13:37+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-autorizzazione-luso-emergenza-premivibart-la-profilassi-pre-esposizione/art-4_tab1_pag79/ 2024-05-12T22:18:45+00:00 https://www.med-life.it/number_articles/tml-n-10-2024-autorizzazione-luso-emergenza-premivibart-la-profilassi-pre-esposizione/art-4_descr_pag80/ 2024-05-12T22:19:43+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab1_81/ 2024-05-26T09:59:36+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab2_82/ 2024-05-26T10:00:31+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab3_83/ 2024-05-26T10:01:38+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab4_84/ 2024-05-26T10:02:20+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab5_85/ 2024-05-26T10:03:52+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab6_86/ 2024-05-26T10:05:08+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/tab7_87/ 2024-05-26T10:06:06+00:00 https://www.med-life.it/number_articles/tml-n-11-2024-farmaci-lipertensione/descrizione_88/ 2024-05-26T10:07:30+00:00 https://www.med-life.it/number_articles/ad-n-2782024-domande-frequenti-sulle-reazioni-avverse-del-metilfenidato/tab-1-2/ 2024-06-04T20:24:25+00:00 https://www.med-life.it/number_articles/ad-n-2782024-domande-frequenti-sulle-reazioni-avverse-del-metilfenidato/biblio-2-2/ 2024-06-04T20:30:48+00:00 https://www.med-life.it/number_articles/ad-n-2782024-domande-frequenti-sulle-reazioni-avverse-del-metilfenidato/biblio-1-2/ 2024-06-04T20:30:51+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-farmaci-la-pediculosi-del-capo/puntichiave_89/ 2024-06-04T20:45:46+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-farmaci-la-pediculosi-del-capo/descr1_90/ 2024-06-04T20:53:18+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-farmaci-la-pediculosi-del-capo/descr2_90/ 2024-06-04T20:53:20+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-aprocitentan-lipertensione/tab1_91/ 2024-06-04T21:04:47+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-aprocitentan-lipertensione/puntichiave_92/ 2024-06-04T21:05:06+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-aprocitentan-lipertensione/tab2_92/ 2024-06-04T21:07:21+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-aprocitentan-lipertensione/descr_93/ 2024-06-04T21:09:18+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-budesonide-sospensione-orale-lesofagite-eosinofila/tab1_93/ 2024-06-04T21:16:06+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-budesonide-sospensione-orale-lesofagite-eosinofila/tab2_93/ 2024-06-04T21:16:45+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-budesonide-sospensione-orale-lesofagite-eosinofila/puntichiave_94/ 2024-06-04T21:17:46+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-budesonide-sospensione-orale-lesofagite-eosinofila/descr_94/ 2024-06-04T21:19:42+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-budesonide-sospensione-orale-lesofagite-eosinofila/descr_95/ 2024-06-04T21:19:56+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-unaltra-terapia-genica-lemofilia-b/puntichiave_95/ 2024-06-04T21:26:03+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-unaltra-terapia-genica-lemofilia-b/descr-95/ 2024-06-04T21:27:35+00:00 https://www.med-life.it/number_articles/tml-n-12-2024-ritiro-volontario-relyvrio/descr_96/ 2024-06-04T21:31:37+00:00 https://www.med-life.it/alcune-interazioni-gli-antidepressivi/tml_online_tab-25-2023-web/ 2024-06-06T20:05:32+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-gepirone-la-depressione/art-1_tab1_pag97/ 2024-06-22T16:55:06+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-gepirone-la-depressione/art-1_tab2_pag97/ 2024-06-22T16:55:08+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-gepirone-la-depressione/art-1_puntichiave_pag98/ 2024-06-22T16:57:37+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-gepirone-la-depressione/art-1_descr_pag99/ 2024-06-22T17:01:07+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-lotilaner-la-blefarite-demodex/art-2_punti_pag99/ 2024-06-22T17:08:38+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-lotilaner-la-blefarite-demodex/art-2_tab1_pag99/ 2024-06-22T17:09:53+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-lotilaner-la-blefarite-demodex/art-2_tab2_pag100/ 2024-06-22T17:09:54+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-lotilaner-la-blefarite-demodex/art-2_descr_pag100/ 2024-06-22T17:11:17+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-fentolamina-oftalmica-la-midriasi-indotta-farmaci/art-3_punti_pag101/ 2024-06-22T17:16:46+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-fentolamina-oftalmica-la-midriasi-indotta-farmaci/art-3_desc_pag101/ 2024-06-22T17:18:04+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/art-3_tab1_pag102/ 2024-06-22T17:21:58+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/art-3_tab2_pag102/ 2024-06-22T17:22:51+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/art-3_tab3_pag103/ 2024-06-22T17:23:43+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/art-3_punti_pag103/ 2024-06-22T17:25:54+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/punti-chiave-103/ 2024-06-22T17:26:34+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/art-3_desc_pag103/ 2024-06-22T17:27:14+00:00 https://www.med-life.it/number_articles/tml-n-13-2024-rezafungina-la-candidosi-invasiva/art-3_desc_pag104/ 2024-06-22T17:27:16+00:00 https://www.med-life.it/?attachment_id=30713 2024-07-05T08:18:18+00:00 https://www.med-life.it/number_articles/tml-n-14-2024-farmaci-losteoporosi-postmenopausa/puntichiave_105/ 2024-07-13T20:07:53+00:00 https://www.med-life.it/number_articles/tml-n-14-2024-farmaci-losteoporosi-postmenopausa/tab1_107/ 2024-07-13T20:08:59+00:00 https://www.med-life.it/number_articles/tml-n-14-2024-farmaci-losteoporosi-postmenopausa/tab2_108/ 2024-07-13T20:09:03+00:00 https://www.med-life.it/number_articles/tml-n-14-2024-farmaci-losteoporosi-postmenopausa/descrizioni_111/ 2024-07-13T20:15:35+00:00 https://www.med-life.it/number_articles/tml-n-14-2024-farmaci-losteoporosi-postmenopausa/descr-2/ 2024-07-13T20:25:16+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-vaccino-rsv-soggetti-eta-compresa-50-59-anni/art-1_tab1_pag-114/ 2024-07-22T21:06:12+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-vaccino-rsv-soggetti-eta-compresa-50-59-anni/art1_descr_114/ 2024-07-22T21:07:23+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-iloprost-geloni/art2_puntichiave_114/ 2024-07-22T21:13:10+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-iloprost-geloni/art2_tab1_pag-114/ 2024-07-22T21:14:22+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-iloprost-geloni/art2_descr_115/ 2024-07-22T21:16:08+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-iloperidone-nuova-indicazione-disturbo-bipolare/art3_tab1_116/ 2024-07-22T21:21:26+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-iloperidone-nuova-indicazione-disturbo-bipolare/art3_descr_116/ 2024-07-22T21:23:04+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-cefepimeenmetazobactam-le-infezioni-complicate-delle-vie-urinarie/art4_tab1_117/ 2024-07-22T21:37:41+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-cefepimeenmetazobactam-le-infezioni-complicate-delle-vie-urinarie/art4_puntichiave_117/ 2024-07-22T21:38:08+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-cefepimeenmetazobactam-le-infezioni-complicate-delle-vie-urinarie/art4_tab2_117/ 2024-07-22T21:39:07+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-cefepimeenmetazobactam-le-infezioni-complicate-delle-vie-urinarie/art4_tab3_118/ 2024-07-22T21:40:13+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-cefepimeenmetazobactam-le-infezioni-complicate-delle-vie-urinarie/art4_descr_118/ 2024-07-22T21:40:52+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-un-biosimilare-dellustekinumab-intercambiabile-stelara/art4_tab1_119/ 2024-07-22T21:47:03+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-un-biosimilare-dellustekinumab-intercambiabile-stelara/art4_descr_119/ 2024-07-22T21:47:38+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-doxiciclina-la-profilassi-post-esposizione-alle-ist/art4_descr2_119/ 2024-07-22T21:52:02+00:00 https://www.med-life.it/number_articles/tml-n-15-2024-doxiciclina-la-profilassi-post-esposizione-alle-ist/descr_ultima/ 2024-07-22T21:52:25+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/figura1_1146/ 2024-07-25T22:29:21+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/figura2_1146/ 2024-07-25T22:31:09+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/figura3_1147/ 2024-07-25T22:31:11+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/figura4_1147/ 2024-07-25T22:33:49+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/figura5_1148/ 2024-07-25T22:33:51+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/figura6_1149/ 2024-07-25T22:34:56+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/biblio-1-ad-279/ 2024-07-25T22:37:28+00:00 https://www.med-life.it/number_articles/ad-n-2792024-influenze-ormonali-sul-rischio-meningioma-nelle-donne/biblio-2-ad-279/ 2024-07-25T22:37:30+00:00 https://www.med-life.it/number_articles/tml-n-16-2024-farmaci-lepilessia/art-1_tab1_121/ 2024-08-05T19:37:45+00:00 https://www.med-life.it/number_articles/tml-n-16-2024-farmaci-lepilessia/art-1_tab2_124/ 2024-08-05T20:50:38+00:00 https://www.med-life.it/number_articles/tml-n-16-2024-farmaci-lepilessia/art-1_tab3_125/ 2024-08-05T20:50:42+00:00 https://www.med-life.it/number_articles/tml-n-16-2024-farmaci-lepilessia/art-1_tab4_126/ 2024-08-05T20:50:46+00:00 https://www.med-life.it/number_articles/tml-n-16-2024-farmaci-lepilessia/art-1_descr_127/ 2024-08-05T20:52:16+00:00 https://www.med-life.it/number_articles/tml-n-16-2024-farmaci-lepilessia/art-1_descr_128/ 2024-08-05T20:52:20+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-donanemab-la-malattia-alzheimer/puntichiave_129/ 2024-08-25T15:48:17+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-donanemab-la-malattia-alzheimer/tab1_129/ 2024-08-25T15:49:04+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-donanemab-la-malattia-alzheimer/tab2_130/ 2024-08-25T15:49:43+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-donanemab-la-malattia-alzheimer/descr1_131/ 2024-08-25T15:51:35+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-ensifentrina-la-bpco/descr2_131/ 2024-08-25T15:58:54+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-ensifentrina-la-bpco/puntichiave_131/ 2024-08-25T15:59:40+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-ensifentrina-la-bpco/tab1_131/ 2024-08-25T16:00:27+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-ensifentrina-la-bpco/tab2_132/ 2024-08-25T16:01:18+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-ensifentrina-la-bpco/descr_132/ 2024-08-25T16:02:54+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-sofpironio-liperidrosi-ascellare-primaria/tab1_133/ 2024-08-25T16:08:34+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-sofpironio-liperidrosi-ascellare-primaria/puntichiave_133/ 2024-08-25T16:09:02+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-sofpironio-liperidrosi-ascellare-primaria/descr_134/ 2024-08-25T16:11:08+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-efbemalenograstim-alfa-la-prevenzione-della-neutropenia-febbrile/puntichiave_134/ 2024-08-25T16:20:17+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-efbemalenograstim-alfa-la-prevenzione-della-neutropenia-febbrile/descr_135/ 2024-08-25T16:21:48+00:00 https://www.med-life.it/number_articles/tml-n-17-2024-indicazione-ampliata-elevidys/descr2_135/ 2024-08-25T16:26:13+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_137_desc/ 2024-09-03T20:44:21+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_137_tab2/ 2024-09-03T20:45:05+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_138_tab3/ 2024-09-03T20:46:04+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_139_tab4/ 2024-09-03T20:47:50+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_140_tab2/ 2024-09-03T20:49:41+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_141_tab3/ 2024-09-03T20:51:53+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_142_tab4/ 2024-09-03T20:54:34+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_142_descr/ 2024-09-03T20:56:02+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_143_descr2/ 2024-09-03T20:56:26+00:00 https://www.med-life.it/number_articles/tml-n-18-2024-farmaci-la-bpco/art_1_pag_144_descr_ultima/ 2024-09-03T20:56:49+00:00 https://www.med-life.it/number_articles/ad-n-2802024-uno-studio-del-potenziale-dipendenza-pregabalin-gabapentin/tab1_pag_1152/ 2024-09-09T20:44:58+00:00 https://www.med-life.it/number_articles/ad-n-2802024-uno-studio-del-potenziale-dipendenza-pregabalin-gabapentin/tab2_pag_1153/ 2024-09-09T20:46:55+00:00 https://www.med-life.it/number_articles/ad-n-2802024-uno-studio-del-potenziale-dipendenza-pregabalin-gabapentin/biblioad280/ 2024-09-09T20:49:47+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag145_nota/ 2024-09-16T20:28:55+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag145_tab1/ 2024-09-16T20:29:53+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag146_puntichiave/ 2024-09-16T20:30:42+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag147_tab2/ 2024-09-16T20:32:29+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag149_descr_1/ 2024-09-16T20:35:16+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag149_descr_2/ 2024-09-16T20:35:39+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-vaccino-antinfluenzale-2024-2025/art_1_pag150_descr1/ 2024-09-16T20:36:00+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-roflumilast-crema-la-dermatite-atopica/art_2_pag150_puntichiave/ 2024-09-16T20:52:28+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-roflumilast-crema-la-dermatite-atopica/art_2_pag151_tab1/ 2024-09-16T20:53:55+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-roflumilast-crema-la-dermatite-atopica/art_2_pag151_descr/ 2024-09-16T20:54:52+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-nuove-formulazioni-dei-vaccini-pfizer-moderna-2024-2025/art_2_pag152_tab1/ 2024-09-16T21:01:35+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-nuove-formulazioni-dei-vaccini-pfizer-moderna-2024-2025/art_2_pag152_descr_1/ 2024-09-16T21:02:13+00:00 https://www.med-life.it/number_articles/tml-n-19-2024-nuove-formulazioni-dei-vaccini-pfizer-moderna-2024-2025/art_2_pag152_descr_2/ 2024-09-16T21:02:14+00:00 https://www.med-life.it/number_articles/tml-n-20-2024-farmaci-la-psoriasi-placche/157_tab_2/ 2024-10-03T21:21:01+00:00 https://www.med-life.it/number_articles/tml-n-20-2024-farmaci-la-psoriasi-placche/159_desc_1/ 2024-10-03T21:25:10+00:00 https://www.med-life.it/number_articles/tml-n-20-2024-farmaci-la-psoriasi-placche/159_desc_2/ 2024-10-03T21:25:52+00:00 https://www.med-life.it/number_articles/tml-n-20-2024-farmaci-la-psoriasi-placche/160_desc_1/ 2024-10-03T21:30:54+00:00 https://www.med-life.it/number_articles/tml-n-20-2024-farmaci-la-psoriasi-placche/160_desc_2/ 2024-10-03T21:32:35+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/acronimi_161/ 2024-10-21T20:21:57+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/art_1_pag163/ 2024-10-21T20:23:07+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/puntichiave_161/ 2024-10-21T20:23:40+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/tab1_162/ 2024-10-21T20:24:54+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/tab2_162/ 2024-10-21T20:26:36+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/contenutiaggiuntivi_163/ 2024-10-21T20:28:40+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-pneumococcico-coniugato-21-virus/descr_163/ 2024-10-21T20:29:18+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-adrenalina-spray-nasale-lanafilassi/art_1_pag163-2/ 2024-10-21T20:37:01+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-adrenalina-spray-nasale-lanafilassi/art_1_descr_164/ 2024-10-21T20:38:58+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-vonoprazan-la-gerd-non-erosiva/art_2_puntichiave_165/ 2024-10-21T20:45:52+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-vonoprazan-la-gerd-non-erosiva/art_2_descr_165/ 2024-10-21T20:47:37+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-lrsv-gli-adulti-eta-%e2%89%a560-anni/art_3_puntichiave_165/ 2024-10-21T20:53:40+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-lrsv-gli-adulti-eta-%e2%89%a560-anni/art_3_tab_1_166/ 2024-10-21T20:54:40+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-lrsv-gli-adulti-eta-%e2%89%a560-anni/art_3_tab_2_166/ 2024-10-21T20:55:59+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-lrsv-gli-adulti-eta-%e2%89%a560-anni/art_3_tab_3_166/ 2024-10-21T20:56:40+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-un-vaccino-lrsv-gli-adulti-eta-%e2%89%a560-anni/art_3_descr_1_167/ 2024-10-21T20:58:29+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-nuova-avvertenza-fezolinetant/art_3_descr_2_167/ 2024-10-21T21:07:24+00:00 https://www.med-life.it/number_articles/tml-n-21-2024-nuova-avvertenza-fezolinetant/art_3_prossimamentecontenuti_167/ 2024-10-21T21:08:04+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-farmaci-linfezione-virus-dellepatite-c/pag_169_punti/ 2024-10-30T23:03:30+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-farmaci-linfezione-virus-dellepatite-c/pag_170_tab1-2/ 2024-10-30T23:04:31+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-farmaci-linfezione-virus-dellepatite-c/pag_171_tab2-2/ 2024-10-30T23:07:25+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-farmaci-linfezione-virus-dellepatite-c/pag_173_desc/ 2024-10-30T23:13:16+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-farmaci-linfezione-virus-dellepatite-c/pag_174_desc_2/ 2024-10-30T23:13:57+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-farmaci-linfezione-virus-dellepatite-c/pag_174_desc/ 2024-10-30T23:14:23+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-un-vaccino-antinfluenzale-autosomministrazione/pag_175_desc_1/ 2024-10-30T23:36:55+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-vaccino-novavax-2024-2025/pag_175_tab_1/ 2024-10-30T23:40:12+00:00 https://www.med-life.it/number_articles/tml-n-22-2024-vaccino-novavax-2024-2025/pag_176_descr/ 2024-10-30T23:41:57+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-xanomelinatrospio-la-schizofrenia/pag-177_puntichiave/ 2024-11-11T21:21:23+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-xanomelinatrospio-la-schizofrenia/pag-177_tab_1/ 2024-11-11T21:21:40+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-xanomelinatrospio-la-schizofrenia/pag-179_desc/ 2024-11-11T21:24:49+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-179_puntichiave/ 2024-11-11T21:33:11+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-179_tab_1/ 2024-11-11T21:34:10+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-180_tab_2/ 2024-11-11T21:35:29+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-180_tab_3/ 2024-11-11T21:36:49+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-181_tab_4/ 2024-11-11T21:38:54+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-181_desc_1/ 2024-11-11T21:39:40+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-lebrikizumab-la-dermatite-atopica/pag-181_desc_2/ 2024-11-11T21:39:59+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-un-gel-banco-la-disfunzione-erettile/pag-182_puntichiave/ 2024-11-11T21:52:19+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-un-gel-banco-la-disfunzione-erettile/pag-182_desc/ 2024-11-11T21:53:22+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-risankizumab-la-colite-ulcerosa/pag-183_tab1/ 2024-11-11T22:01:17+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-risankizumab-la-colite-ulcerosa/pag-184_puntichiave/ 2024-11-11T22:03:26+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-risankizumab-la-colite-ulcerosa/pag-184_contenutiaggiuntivi/ 2024-11-11T22:05:01+00:00 https://www.med-life.it/number_articles/tml-n-23-2024-risankizumab-la-colite-ulcerosa/pag-184_desc/ 2024-11-11T22:05:18+00:00 https://www.med-life.it/number_articles/ad-n-2812024-anomalie-imaging-correlate-allamiloide-nella-terapia-lamiloidosi-la-malattia-alzheimer-revisione-narrativa/screenshot-2024-11-17-alle-08-42-55/ 2024-11-17T07:43:12+00:00 https://www.med-life.it/number_articles/ad-n-2812024-anomalie-imaging-correlate-allamiloide-nella-terapia-lamiloidosi-la-malattia-alzheimer-revisione-narrativa/screenshot-2024-11-17-alle-08-51-59/ 2024-11-17T07:52:28+00:00 https://www.med-life.it/?attachment_id=31374 2024-11-20T10:50:49+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-185_puntichiave/ 2024-11-27T21:16:01+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-186_tab_2/ 2024-11-27T21:19:20+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-187_tab_2/ 2024-11-27T21:20:16+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-188_tab_3/ 2024-11-27T21:23:21+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-189_tab_3/ 2024-11-27T21:25:11+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-190_tab_4/ 2024-11-27T21:26:46+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-191_desc/ 2024-11-27T21:30:38+00:00 https://www.med-life.it/number_articles/tml-n-24-2024-farmaci-lasma/pag-192_desc_2/ 2024-11-27T21:31:15+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-farmaci-antivirali-linfluenza-stagionale-2024-2025/pa-193_puntichiave/ 2024-12-08T17:07:50+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-farmaci-antivirali-linfluenza-stagionale-2024-2025/pa-193_tab_1/ 2024-12-08T17:08:07+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-farmaci-antivirali-linfluenza-stagionale-2024-2025/pa-195_tab2/ 2024-12-08T17:10:10+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-farmaci-antivirali-linfluenza-stagionale-2024-2025/pa-197_desc_1/ 2024-12-08T17:13:26+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-farmaci-antivirali-linfluenza-stagionale-2024-2025/pa-197_desc_2/ 2024-12-08T17:13:43+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-farmaci-antivirali-linfluenza-stagionale-2024-2025/pa-198_desc_1/ 2024-12-08T17:13:59+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-marstacimab-lemofilia-b/pa-198_tab_1/ 2024-12-08T17:35:14+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-marstacimab-lemofilia-b/pa-199_puntichiave/ 2024-12-08T17:35:28+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-marstacimab-lemofilia-b/pa-199_desc/ 2024-12-08T17:37:42+00:00 https://www.med-life.it/number_articles/tml-n-25-2024-un-contraccettivo-ormonale-compresse-disintegrabili-via-orale/ultima_desc/ 2024-12-08T17:47:07+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-allarme-della-fda-aspirazione-polmonare-gli-agonisti-del-recettore-del-glp-1/202_descr_1/ 2024-12-23T08:23:41+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-elafibranor-la-colangite-biliare-primaria/202_descr_2/ 2024-12-23T08:28:07+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-elafibranor-la-colangite-biliare-primaria/202_puntichiave/ 2024-12-23T08:29:29+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-elafibranor-la-colangite-biliare-primaria/202_tab_1/ 2024-12-23T08:30:34+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-elafibranor-la-colangite-biliare-primaria/203_tab_2/ 2024-12-23T08:30:49+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-elafibranor-la-colangite-biliare-primaria/204_descr_1/ 2024-12-23T08:33:21+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-givinostat-la-distrofia-muscolare-duchenne/204_tab_1/ 2024-12-23T08:41:18+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-givinostat-la-distrofia-muscolare-duchenne/205_punti/ 2024-12-23T08:42:57+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-givinostat-la-distrofia-muscolare-duchenne/205_desc_1/ 2024-12-23T08:44:36+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-givinostat-la-distrofia-muscolare-duchenne/205_desc_2/ 2024-12-23T08:44:48+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-clonidina-sospensione-orale-ladhd/205_tab_1/ 2024-12-23T08:51:13+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-clonidina-sospensione-orale-ladhd/206_puntichiave/ 2024-12-23T08:52:01+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-clonidina-sospensione-orale-ladhd/206_descr/ 2024-12-23T08:53:58+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-carbidopalevodopa-rilascio-prolungato-morbo-parkinson/207_puntichiave/ 2024-12-23T08:58:53+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-carbidopalevodopa-rilascio-prolungato-morbo-parkinson/207_tab_1/ 2024-12-23T09:00:31+00:00 https://www.med-life.it/number_articles/tml-n-26-2024-carbidopalevodopa-rilascio-prolungato-morbo-parkinson/207_desc/ 2024-12-23T09:01:33+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-farmaci-la-degenarzione-maculare-senile/pag_1_puntichiave/ 2025-01-04T11:02:52+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-farmaci-la-degenarzione-maculare-senile/pag_3_tab_1/ 2025-01-04T11:06:45+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-farmaci-la-degenarzione-maculare-senile/pag_3_tab_1-2/ 2025-01-04T11:07:20+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-farmaci-la-degenarzione-maculare-senile/screenshot-2025-01-04-alle-12-07-58/ 2025-01-04T11:08:15+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-farmaci-la-degenarzione-maculare-senile/pag_4_desc_1/ 2025-01-04T11:11:35+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-farmaci-la-degenarzione-maculare-senile/pag_4_desc_2/ 2025-01-04T11:11:53+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-soluzione-oftalmica-pilocarpina-allo-04-la-presbiopia/pag_5_puntichiave/ 2025-01-04T12:20:18+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-soluzione-oftalmica-pilocarpina-allo-04-la-presbiopia/pag_5_tab_1/ 2025-01-04T12:21:48+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-soluzione-oftalmica-pilocarpina-allo-04-la-presbiopia/pag_6_desc/ 2025-01-04T12:23:34+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-infusione-sottocutanea-foscarbidopafoslevodopa-la-malattia-parkinson/pag_7_desc/ 2025-01-04T12:33:00+00:00 https://www.med-life.it/number_articles/tml-n-1-2025-infusione-sottocutanea-foscarbidopafoslevodopa-la-malattia-parkinson/pag_7_puntichiave/ 2025-01-04T12:34:03+00:00 https://www.med-life.it/number_articles/ad-n-2822024-studio-delle-reazioni-avverse-al-testosterone-mediante-randomizzazione-mendeliana-protocollo-studio/tab-1-3/ 2025-01-14T22:07:09+00:00 https://www.med-life.it/number_articles/ad-n-2822024-studio-delle-reazioni-avverse-al-testosterone-mediante-randomizzazione-mendeliana-protocollo-studio/tab-2-2/ 2025-01-14T22:08:54+00:00 https://www.med-life.it/number_articles/ad-n-2822024-studio-delle-reazioni-avverse-al-testosterone-mediante-randomizzazione-mendeliana-protocollo-studio/biblio/ 2025-01-14T22:12:35+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-fotobiomodulatore-multilunghezza-donda-la-degenerazione-maculare-senile/9_puntichiave/ 2025-01-16T23:36:25+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-fotobiomodulatore-multilunghezza-donda-la-degenerazione-maculare-senile/10_desc/ 2025-01-16T23:38:15+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-minociclina-orale-bifasica-basso-dosaggio-la-rosacea/10_puntichiave/ 2025-01-16T23:44:01+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-minociclina-orale-bifasica-basso-dosaggio-la-rosacea/10_tab_1/ 2025-01-16T23:45:36+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-minociclina-orale-bifasica-basso-dosaggio-la-rosacea/11_tab_2/ 2025-01-16T23:45:49+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-minociclina-orale-bifasica-basso-dosaggio-la-rosacea/11_desc/ 2025-01-16T23:48:05+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-dupilumab-la-bpco/12_puntichiave/ 2025-01-16T23:56:02+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-dupilumab-la-bpco/12_tab_1/ 2025-01-16T23:56:16+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-dupilumab-la-bpco/13_desc/ 2025-01-16T23:57:07+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-seladelpar-la-colangite-biliare-primaria/13_puntichiave/ 2025-01-17T00:03:18+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-seladelpar-la-colangite-biliare-primaria/14_tab_1/ 2025-01-17T00:05:03+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-seladelpar-la-colangite-biliare-primaria/14_desc/ 2025-01-17T00:07:01+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-seladelpar-la-colangite-biliare-primaria/15_desc/ 2025-01-17T00:07:16+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-zenocutuzumab-l-nsclc-ladenocarcinoma-pancreatico/15_puntichiave/ 2025-01-17T00:15:16+00:00 https://www.med-life.it/number_articles/tml-n-2-2025-zenocutuzumab-l-nsclc-ladenocarcinoma-pancreatico/16_desc/ 2025-01-17T00:16:47+00:00 https://www.med-life.it/number_articles/tml-n-3-2025-farmaci-la-sindrome-del-colon-irritabile/puntichiave_1_17/ 2025-02-04T22:16:47+00:00 https://www.med-life.it/number_articles/tml-n-3-2025-farmaci-la-sindrome-del-colon-irritabile/tab_1_18/ 2025-02-04T22:17:29+00:00 https://www.med-life.it/number_articles/tml-n-3-2025-farmaci-la-sindrome-del-colon-irritabile/tab_2_19/ 2025-02-04T22:19:18+00:00 https://www.med-life.it/number_articles/tml-n-3-2025-farmaci-la-sindrome-del-colon-irritabile/tab_3_21/ 2025-02-04T22:27:54+00:00 https://www.med-life.it/number_articles/tml-n-3-2025-farmaci-la-sindrome-del-colon-irritabile/contenuti_25/ 2025-02-04T22:28:37+00:00 https://www.med-life.it/number_articles/tml-n-3-2025-farmaci-la-sindrome-del-colon-irritabile/descr_ultima-2/ 2025-02-04T22:28:57+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/tml_4-2025_1722-web_w-2/ 2025-02-17T21:17:39+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/pag_26_tab_2/ 2025-02-17T21:17:50+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/pag_26_tab_3/ 2025-02-17T21:19:16+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/pag_26_tab_4/ 2025-02-17T21:19:30+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/pag_27_puntichiave/ 2025-02-17T21:21:43+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/pag_27_contenuti/ 2025-02-17T21:23:29+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nemolizumab-la-dermatite-atopica/pag_27_desc_1/ 2025-02-17T21:23:43+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_27_acronimi_1/ 2025-02-17T21:30:45+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_27_tab_1/ 2025-02-17T21:31:47+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_28_tab_2/ 2025-02-17T21:33:02+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_28_tab_3/ 2025-02-17T21:33:28+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_28_tab_4/ 2025-02-17T21:33:43+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_29_puntichiave/ 2025-02-17T21:36:03+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-vadadustat-lanemia-associata-allinsufficienza-renale-cronica/pag_29_desc/ 2025-02-17T21:38:42+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-tirzepatide-lapnea-ostruttiva-del-sonno/pag_30_punti/ 2025-02-17T21:45:05+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-tirzepatide-lapnea-ostruttiva-del-sonno/pag_31_desc_1/ 2025-02-17T21:47:56+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nuova-avvertenza-vaccini-lrsv-arexvy-abrysvo/pag_31_tab_1/ 2025-02-17T21:53:58+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nuova-avvertenza-vaccini-lrsv-arexvy-abrysvo/pag_32_desc_1/ 2025-02-17T21:54:43+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-nuova-avvertenza-vaccini-lrsv-arexvy-abrysvo/pag_31_desc_2/ 2025-02-17T21:56:23+00:00 https://www.med-life.it/number_articles/tml-n-4-2025-anafilassi-glatiramer-acetato/pag_32_desc_2/ 2025-02-17T21:59:22+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-suzetrigina-un-bloccante-dei-canali-del-sodio-dolore-acuto/33_tab_1/ 2025-02-26T21:37:05+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-suzetrigina-un-bloccante-dei-canali-del-sodio-dolore-acuto/34_puntichiave/ 2025-02-26T21:39:03+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-suzetrigina-un-bloccante-dei-canali-del-sodio-dolore-acuto/35_desc/ 2025-02-26T21:40:09+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-farmaci-la-sindrome-dellocchio-secco/35_puntichiave/ 2025-02-26T21:46:13+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-farmaci-la-sindrome-dellocchio-secco/36_tab_1/ 2025-02-26T21:48:05+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-farmaci-la-sindrome-dellocchio-secco/37_descr/ 2025-02-26T21:51:13+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-tapinarof-crema-la-dermatite-atopica/37_tab_1/ 2025-02-26T22:07:49+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-tapinarof-crema-la-dermatite-atopica/38_puntichiave/ 2025-02-26T22:09:50+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-tapinarof-crema-la-dermatite-atopica/38_descr/ 2025-02-26T22:11:35+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-unindicazione-renale-la-semaglutide/39_tab_1/ 2025-02-26T22:18:02+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-unindicazione-renale-la-semaglutide/tab_2/ 2025-02-26T22:19:07+00:00 https://www.med-life.it/number_articles/tml-n-5-2025-unindicazione-renale-la-semaglutide/40_descr/ 2025-02-26T22:20:37+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/41_acronimi/ 2025-03-19T22:37:59+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/41_puntichiave/ 2025-03-19T22:38:47+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/42_tab_1/ 2025-03-19T22:39:33+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/42_tab_2/ 2025-03-19T22:45:18+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/43_tab_3/ 2025-03-19T22:46:50+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/43_desc/ 2025-03-19T22:48:08+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/44_desc/ 2025-03-19T22:48:46+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-formulazione-iniettabile-monodose-testosterone-cipionato/44_tab_1/ 2025-03-19T23:02:25+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-formulazione-iniettabile-monodose-testosterone-cipionato/45_descr/ 2025-03-19T23:03:05+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-acoramidis-la-cardiomiopatia-amiloide-transtiretina/45_tab_1/ 2025-03-19T23:11:23+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-acoramidis-la-cardiomiopatia-amiloide-transtiretina/45_puntichiave/ 2025-03-19T23:12:34+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-acoramidis-la-cardiomiopatia-amiloide-transtiretina/46_desc/ 2025-03-19T23:14:13+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-guselkumab-la-colite-ulcerosa/46_puntichiave/ 2025-03-19T23:19:25+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-guselkumab-la-colite-ulcerosa/47_tab_1/ 2025-03-19T23:20:42+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-guselkumab-la-colite-ulcerosa/48_desc_1/ 2025-03-19T23:22:51+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-guselkumab-la-colite-ulcerosa/48_desc_2/ 2025-03-19T23:23:04+00:00 https://www.med-life.it/number_articles/ad-n-2832025-reazioni-avverse-ai-farmaci-pneumologia/ad_283_tab_1/ 2025-03-22T22:22:16+00:00 https://www.med-life.it/number_articles/ad-n-2832025-reazioni-avverse-ai-farmaci-pneumologia/screenshot-2025-03-22-alle-23-23-00/ 2025-03-22T22:23:12+00:00 https://www.med-life.it/number_articles/ad-n-2832025-reazioni-avverse-ai-farmaci-pneumologia/ad_283_tab_3/ 2025-03-22T22:24:46+00:00 https://www.med-life.it/number_articles/ad-n-2832025-reazioni-avverse-ai-farmaci-pneumologia/ad_283_biblio/ 2025-03-22T22:27:25+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-vanzacaftor-tezacaftor-deutivacaftor-la-fibrosi-cistica/43_desc_unita/ 2025-03-23T22:47:04+00:00 https://www.med-life.it/number_articles/tml-n-6-2025-guselkumab-la-colite-ulcerosa/48_desc_1_unita/ 2025-03-23T22:49:41+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/49_tab_1/ 2025-04-02T20:57:18+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/51_tab_2/ 2025-04-02T21:00:00+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/52_tab_3/ 2025-04-02T21:01:27+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/54_tab_4/ 2025-04-02T21:04:54+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/55_puntichiave/ 2025-04-02T21:06:20+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/55_aggiuntivi/ 2025-04-02T21:07:35+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/56_desc_1/ 2025-04-02T21:07:49+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/56_desc_2/ 2025-04-02T21:08:04+00:00 https://www.med-life.it/number_articles/tml-n-7-2025-trattamento-della-rinite-allergica-della-congiuntivite-allergica/correzione/ 2025-04-02T21:10:47+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-un-secondo-vaccino-meningococcico-pentavalente/57_puntichiave/ 2025-04-14T21:47:20+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-un-secondo-vaccino-meningococcico-pentavalente/58_tab_1/ 2025-04-14T21:47:37+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-un-secondo-vaccino-meningococcico-pentavalente/59_desc_1/ 2025-04-14T21:50:33+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-un-secondo-vaccino-meningococcico-pentavalente/59_desc_2/ 2025-04-14T21:50:41+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-benzgalantamina-la-malattia-alzheimer/60_puntichiave/ 2025-04-14T22:02:05+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-benzgalantamina-la-malattia-alzheimer/60_desc/ 2025-04-14T22:04:04+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-palopegteriparatide-lipoparatiroidismo/60_puntichiave-2/ 2025-04-14T22:09:22+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-palopegteriparatide-lipoparatiroidismo/60_tab_1/ 2025-04-14T22:09:39+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-palopegteriparatide-lipoparatiroidismo/61_puntichiave/ 2025-04-14T22:10:23+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-palopegteriparatide-lipoparatiroidismo/61_tab_2/ 2025-04-14T22:11:54+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-palopegteriparatide-lipoparatiroidismo/62_desc_1/ 2025-04-14T22:13:58+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-modifiche-alle-schede-tecniche-dei-farmaci-base-testosterone/62_desc_2/ 2025-04-14T22:20:16+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-nuova-scheda-tecnica-la-buprenorfina-sottocutanea-volta-al-mese/63_desc_1/ 2025-04-14T22:23:36+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-nuova-scheda-tecnica-la-buprenorfina-sottocutanea-volta-al-mese/63_tab_1/ 2025-04-14T22:23:51+00:00 https://www.med-life.it/number_articles/tml-n-8-2025-lecanemab-volta-al-mese-la-malattia-alzheimer/64_desc/ 2025-04-14T22:29:25+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-farmaci-glaucoma-ad-angolo-aperto/65_puntichiave/ 2025-05-04T20:52:52+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-farmaci-glaucoma-ad-angolo-aperto/66_tab_1/ 2025-05-04T20:53:09+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-farmaci-glaucoma-ad-angolo-aperto/68_desc_1/ 2025-05-04T20:58:15+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-farmaci-glaucoma-ad-angolo-aperto/68_desc_2/ 2025-05-04T20:58:26+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-associazione-dose-fissa-meloxicam-rizatriptan-lemicrania/69_puntichiave/ 2025-05-04T21:15:22+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-associazione-dose-fissa-meloxicam-rizatriptan-lemicrania/69_tab_1/ 2025-05-04T21:18:53+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-associazione-dose-fissa-meloxicam-rizatriptan-lemicrania/70_tab_2/ 2025-05-04T21:21:22+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-associazione-dose-fissa-meloxicam-rizatriptan-lemicrania/70_desc/ 2025-05-04T21:22:28+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-associazione-dose-fissa-meloxicam-rizatriptan-lemicrania/71_desc_2/ 2025-05-04T21:23:30+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-epinefrina-spray-nasale-1-mg/71_tab_1/ 2025-05-04T21:37:00+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-epinefrina-spray-nasale-1-mg/71_desc_3/ 2025-05-04T21:37:37+00:00 https://www.med-life.it/number_articles/tml-n-9-2025-nuova-indicazione-tenecteplase/72_desc/ 2025-05-04T21:41:50+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-un-test-domiciliare-del-dna-nelle-feci-lo-screening-del-tumore-del-colon-retto/73_puntichiave/ 2025-05-12T21:13:08+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-un-test-domiciliare-del-dna-nelle-feci-lo-screening-del-tumore-del-colon-retto/74_tab1/ 2025-05-12T21:14:04+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-un-test-domiciliare-del-dna-nelle-feci-lo-screening-del-tumore-del-colon-retto/75_desc/ 2025-05-12T21:15:28+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-landiololo-controllo-breve-termine-della-frequenza-nella-tachicardia-sopraventricolare/75_tab_1/ 2025-05-12T21:21:35+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-landiololo-controllo-breve-termine-della-frequenza-nella-tachicardia-sopraventricolare/75_puntichiave/ 2025-05-12T21:23:21+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-landiololo-controllo-breve-termine-della-frequenza-nella-tachicardia-sopraventricolare/76_tab2/ 2025-05-12T21:24:03+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-landiololo-controllo-breve-termine-della-frequenza-nella-tachicardia-sopraventricolare/76_desc/ 2025-05-12T21:26:37+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-concizumab-lemofilia-b-inibitori/77_puntichiave/ 2025-05-12T21:32:08+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-concizumab-lemofilia-b-inibitori/78_desc/ 2025-05-12T21:34:57+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-mirikizumab-un-antagonista-dellil-23-la-malattia-crohn/78_puntichiave/ 2025-05-12T21:42:11+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-mirikizumab-un-antagonista-dellil-23-la-malattia-crohn/78_tab1/ 2025-05-12T21:43:35+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-mirikizumab-un-antagonista-dellil-23-la-malattia-crohn/79_tab2/ 2025-05-12T21:43:51+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-mirikizumab-un-antagonista-dellil-23-la-malattia-crohn/80_desc_1/ 2025-05-12T21:45:54+00:00 https://www.med-life.it/number_articles/tml-n-10-2025-un-test-domiciliare-clamidia-gonorrea-tricomoniasi/80_desc_2/ 2025-05-12T21:52:48+00:00 https://www.med-life.it/number_articles/tml-n-11-2025-farmaci-linsufficienza-cardiaca-cronica/82_tab2/ 2025-05-18T16:34:05+00:00 https://www.med-life.it/number_articles/tml-n-11-2025-farmaci-linsufficienza-cardiaca-cronica/81_tab1/ 2025-05-18T16:35:03+00:00 https://www.med-life.it/number_articles/tml-n-11-2025-farmaci-linsufficienza-cardiaca-cronica/83_tab2/ 2025-05-18T16:38:11+00:00 https://www.med-life.it/number_articles/tml-n-11-2025-farmaci-linsufficienza-cardiaca-cronica/87_desc/ 2025-05-18T16:50:20+00:00 https://www.med-life.it/number_articles/tml-n-11-2025-farmaci-linsufficienza-cardiaca-cronica/88_desc/ 2025-05-18T16:50:42+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-uno-iud-al-rame-dosaggio-ridotto/89_tab_1/ 2025-05-28T20:53:20+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-uno-iud-al-rame-dosaggio-ridotto/89_puntichiave/ 2025-05-28T20:54:00+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-uno-iud-al-rame-dosaggio-ridotto/90_tab_2/ 2025-05-28T20:55:17+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-uno-iud-al-rame-dosaggio-ridotto/90_desc/ 2025-05-28T20:56:52+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-un-esame-del-sangue-lo-screening-del-cancro-colorettale/91_tab_1/ 2025-05-28T21:04:56+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-un-esame-del-sangue-lo-screening-del-cancro-colorettale/92_puntichiave/ 2025-05-28T21:05:40+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-un-esame-del-sangue-lo-screening-del-cancro-colorettale/92_desc/ 2025-05-28T21:07:18+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-guselkumab-un-antagonista-dellil-23-la-malattia-crohn/93_tab_1/ 2025-05-28T22:06:21+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-guselkumab-un-antagonista-dellil-23-la-malattia-crohn/93_tab_2/ 2025-05-28T22:06:42+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-guselkumab-un-antagonista-dellil-23-la-malattia-crohn/94_puntichiave/ 2025-05-28T22:08:24+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-guselkumab-un-antagonista-dellil-23-la-malattia-crohn/94_desc/ 2025-05-28T22:09:40+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-prevenzione-del-morbillo/95_descr_1/ 2025-05-28T22:42:41+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-programma-rems-clozapina-un-aggiornamento/95_descr_2/ 2025-05-28T22:45:33+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-un-biosimilare-dellomalizumab-intercambiabile-xolair/95_tab_1/ 2025-05-28T22:48:24+00:00 https://www.med-life.it/number_articles/tml-n-12-2025-un-biosimilare-dellomalizumab-intercambiabile-xolair/ultima_desc-2/ 2025-05-28T22:48:58+00:00 https://www.med-life.it/number_articles/ad-n-2842025-modello-protocollo-studi-clinici-randomizzati-sulla-riduzione-delluso-postoperatorio-prolungato-oppioidi/1170_tab_1/ 2025-06-04T20:18:05+00:00 https://www.med-life.it/number_articles/ad-n-2842025-modello-protocollo-studi-clinici-randomizzati-sulla-riduzione-delluso-postoperatorio-prolungato-oppioidi/1171_grafico/ 2025-06-04T20:19:42+00:00 https://www.med-life.it/number_articles/ad-n-2842025-modello-protocollo-studi-clinici-randomizzati-sulla-riduzione-delluso-postoperatorio-prolungato-oppioidi/1172_tab_2/ 2025-06-04T20:20:19+00:00 https://www.med-life.it/number_articles/ad-n-2842025-modello-protocollo-studi-clinici-randomizzati-sulla-riduzione-delluso-postoperatorio-prolungato-oppioidi/screenshot-2025-06-04-alle-22-23-32/ 2025-06-04T20:23:48+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/97_punti/ 2025-06-23T04:17:39+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/98_tab_1/ 2025-06-23T04:19:56+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/99_tab_2/ 2025-06-23T04:22:02+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/101_desc/ 2025-06-23T04:27:10+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/102_desc_1/ 2025-06-23T04:27:24+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-protezioni-solari/102_desc_2/ 2025-06-23T04:27:38+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-vutrisiran-lamiloidosi-cardiaca-transtiretina/103_puntichiave/ 2025-06-23T05:09:14+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-vutrisiran-lamiloidosi-cardiaca-transtiretina/103_tab_1/ 2025-06-23T05:10:31+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-vutrisiran-lamiloidosi-cardiaca-transtiretina/103_tab_2/ 2025-06-23T05:11:22+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-vutrisiran-lamiloidosi-cardiaca-transtiretina/103_desc/ 2025-06-23T05:12:41+00:00 https://www.med-life.it/number_articles/tml-n-13-2025-merilog-un-biosimilare-novolog/desc_last/ 2025-06-23T05:17:58+00:00